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Abstract 
Osteoporosis is one of the commonest geriatric findings, which causes rapid 
loss in bone mineral density (BMD) and microarchitectural deterioration of bone 
tissues during old age. People with osteoporosis get bone fracture easily and thus 
suffer from loss of mobility and independence, and even threatened with death. Some 
elderly are suffering from back pain even though no fracture occurs. The government 
needs to spend a huge amount of money to manage the osteoporotic related problems 
every year. Unfortunately, as the aging population, more people will suffer from 
osteoporosis and thus, social-economical burden on the problems caused by 
osteoporosis would certainly be increased in the future. 
Since implants for osteoporotic bone fracture fixation are originally 
designed for fracture fixation in young adults whose bone quality is much better than 
that of the elderly, loosening of the implants from the osteoporotic bone after fracture 
fixation is not uncommon. It is necessary to design new implants that can provide 
ultimate function in the treatment of osteoporotic bone fractures. Besides, new drugs 
for treatment of osteoporosis by reversing rapid loss of BMD effectively are needed 
to be investigated. 
Although different animal models have been developed for the study of 
osteoporosis, some of them, like rats and rabbits, are too small for the study of 
ostoeporotic bone fracture fixation. Despite non-human primate are large enough, 
they are so wild that it is difficult for handling. Moreover, the risk of zoonotic disease 
transmission from the non-human primate is relatively high. Dogs, on the other hand, 
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had been reported non-successful as an osteoporotic animal model. Although ewes 
have been demonstrated as a successful animal model for osteoporosis, the hot and 
humid climate in Hong Kong is not suitable for their living. One of our aims is to 
establish a large animal model that has not been reported - the Chinese mountain 
goat, for the studies of osteoporotic bone fracture fixations. We also plan to identify 
the most reliable parameters for assessment of osteopenia in this goat model. 
In our study, 16 skeletally mature goats were randomized for ovariectomy 
(Ovx,以=11) or sham operation (Sham, n=5). Afterwards, the goats were kept for 6 
months for the development of osteopenia. Ovariectomy was confirmed to be 
successful by histology of the excised organ and the decrease in serum estradiol 
concentration. In order to enhance the loss of bone mineral, the ovariectomized goats 
were fed with low calcium diet. Aluminum Step Wedge (ASW) standardized bone 
density (pixel density of the images of the X-ray films standardized with the 
thickness of the ASW calibrator) of the goats at the proximal tibial metaphysis and 
calcaneum were measured by photodensitometry. The bone mineral density (BMD) 
of the iliac crest biopsy was measured by peripheral Quantitative Computed 
Tomography (pQCT). The lumbar vertebrae 2 and 7，as well as the calcaneum and 
humerus of the goat were also harvested for BMD measurement after the goat had 
been euthanized. Blood and urine were also collected monthly for monitoring the 
changes of bone forming (bone-specific alkaline phosphatase, BALP and osteocalcin, 
OC) and bone resorption biochemical markers (deoxypyridinoline), respectively. Six 
months after the ovariectomy or sham operation, distal metaphysis of femur and tibia 
as well as the lumbar vertebra 4 (L4) were screwed with cancellous screws while the 
femoral and tibial diaphysis were screwed with cortex screws. In order to test the 
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bone quality in ovariectomized goats, screw pullout test at L4, distal femoral and 
tibial metaphysis (as cancellous region) as well as femoral and tibial diaphysis (as 
cortical region) were performed. Compression test at calcaneum and humeral head 
were also carried out after the goat had been euthanized. 
Our results indicate that the osteopenic goat model was successfully 
established by ovariectomy and low calcium diet. The standardized bone density of 
both the proximal metaphysis of tibia and the calcaneum of the Ovx group decreased 
gradually after ovariectomy and significant difference of 21.6 % and 18.1 % 
respectively, was found 6 months post-operatively, while that of the Sham group 
increased with no statistical significance. Consistent observation was also found in 
the BMD of iliac crest biopsy, where the BMD of the Ovx group was significantly 
reduced by 31.7% after 6 months while no significant change was found in the Sham 
group. BMD of L2, L7, calcaneum and humeral head of the Ovx group was also 
lower than that of the Sham group significantly. 
Concerning the mechanical properties of the bone, our results indicate that 
the bone quality of the Ovx group was poor compared to the Sham group after six 
months of operation. The ultimate screw pullout strength at the cancellous regions 
(L4, distal femoral and tibial metaphysis) was reduced significantly by 25.0 %, 48.8 
% and 40.8 % respectively while that at the cortical regions (femoral and tibial 
diaphysis) was reduced by 10.9 % and 11.0 % respectively, although with no 
statistical significant. The compression energy of the calcaneum and humeral head of 
the ovariectomized goat was also reduced significantly by 56.3 % and 60.7 %, 
respectively. 
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For the biochemical markers, there was no statistical difference between the 
two groups six months after the operation although the BALP and OC activity of the 
Ovx group increased significantly. It may be due to the lack of specificity of the 
methods and/or antibodies that we used in this study when applied on goat. It may 
also be due to the large internal variation of the biochemical markers in the goat. 
Taken together, the osteopenic Chinese goat animal model was successfully 
established in our laboratory by ovariectomy and low calcium diet as demonstrated 
by the decrease in BMD and mechanical properties of bone at different sites. The 
skeletal maturity of the goats is also a key factor for creating the model in six months 
as we failed to establish the osteopenic model with skeletally immature goats in this 
period. In addition, BMD measurement of the iliac crest biopsy is the best method 
for monitoring the successful establishment of the osteopenic model due to the 
availabilty of baseline values and also due to the high precision and repeatability of 
the pQCT. 
Our osteopenic goat model is beneficial for testing implant designs and 
fixation techniques on the treatment of osteoporotic bone fractures as well as drug 
treatment of osteoporosis. Hopefully, elderly can enjoy a better life in the future after 










































48. 8%和40.8%。在皮質區（股骨幹和脛骨幹）則依次低10. 9%和11.0 
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Introduction 
Chapter 1: Introduction 
Bone is the hardest tissue in the body and has two unique and major 
functions: mechanical and metabolic. The mechanical function provides the 
structural framework for the organism that permits support, locomotion and 
protection of internal organs. The metabolic function of bone tissue consists of 
storage of calcium that can be mobilized when needed for vital body functions. 
Phosphate and other ions are also stored in bone. Moreover, another function of bone 
is as a site for hematopoiesis. 
Osteoporosis is a metabolic bone disorder in which there is a decrease in the 
amount of normally mineralized bone and disturbance in bone microarchitecture. As 
a result, bone becomes fragile and will be broken easily. According to a committee 
formed by The World Health Organization (WHO) in 1994, osteoporosis is defined 
as a condition that the bone mineral density (BMD) is more than 2.5 standard 
deviations below the mean of young normal people (Kanis J.A. et al., 1994). 
Osteoporosis happens when bone resorption rate is faster than bone formation rate of 
a body, which finally leads to a continuous decrease in BMD of the body. 
Osteoporotic bone can no longer provide its original functions. Furthermore, 
osteoporotic bone fracture is difficult to be fixed because of its low 'holding power，. 
Loosening of implants from osteoporotic bone is not uncommon to be observed. The 
government needs to spend huge amount of money dealing with this problem 
annually. More seriously, owing to the worldwide aging population, osteoporosis 
becomes a global phenomenon. 
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Introduction 
1.1 Epidemiology of Osteoporosis 
1.1.1 Prevalence and social aspects of osteoporosis 
Aging population is becoming a global phenomenon. No matter in 
developed or developing countries, the fast-paced socio-economic development has 
resulted in a sharp decline in fertility rates in the population. Together with rising 
living standards and improved health care, the average age of human beings is 
getting older and older (1990). Geriatric problems therefore cause a great social-
medical burden to governments gradually (Lau E.M.C., 1997a). 
Osteoporosis is one of the commonest geriatric problems. The medication of 
osteoporosis and its attendant fractures cost $5.2 billion in the US (Philips S. et al., 
1988) and £615 million in the UK annually (Kanis J.A. et al., 1992). In Hong Kong, 
the cost was estimated as HK$510 million in 1995 (Osteoporosis Working Group, 
1998). More seriously, with the sharp increase of aged population, it is forecasted 
that the expenditure will increase at least 3 times in US in 2040 (Or H.Z. et al., 
1999). 
1.1.2 Osteoporotic bone fractur e 
Normal, healthy bone can be fractured by trauma of sufficient force. Thus, 
osteoporotic fractures are those either occur spontaneously, or as the result of mild or 
moderate trauma. Mild or moderate trauma is usually defined as a fall to the ground 
from a sitting or standing positions. Such trauma would not ordinarily cause fractures 
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in a healthy, young person. 
Osteoporosis would be nothing, would be little medical interest or concern. 
It is its associated fracture outcome, along with the related pain, disability, cost, 
morbidity, and mortality, which ultimately defines osteoporosis. In other words, 
people suffering from osteoporosis are threatened by bone fractures frequently 
(Audekercke R.V. et al., 1994). Meanwhile, fractures around hip, vertebral and 
forearm are the commonest osteoporotic bone fractures (Lau E.M.C., 1997a; Cooper 
C. et al., 1992b; Melton HI L.J. et al., 1997; Lau E.M.C., 1997b). 
The most recent figures that have been published in Medicare data base also 
set the figure at approximately 275,000 new osteoporotic hip fractures each year in 
the US (Jacobsen S.J. et al., 1990). Hip fracture is so devastating to the elderly that 
they lose their independence immediately. As a result, most of the patients need 
surgical intervention to fix the fracture. Surgical risk is therefore increased. It is 
reported that between 10 and 20 % of hip fracture patients die within a year of the 
event. Among those who survive, almost two-thirds remain disabled (Ciimmings 
S.R. (it al., 1985). 
In Hong Kong, with the socio-economic developments, the incidence of hip 
fracture increased by more than twofold in the last two decades (Lau E.M.C., 1997a). 
More seriously, according to projections by the WHO, there will be a total of 900 
million men and women 65 years of age and older in Asia by the year 2050, more 
than 50% of all these hip fractures will then happen in Asia at that time (Cooper C. et 
al., 1992a; Melton III L.J., 1993). 
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Osteoporotic vertebral fractures, on the other hand, are very difficult to be 
observed due to their gradual and often painless onset. However, it is estimated that 
20-25 % of women 50 years of age and over have these fractures (Cooper C. et al” 
1992c; Jensen G.F. et al., 1982). In Hong Kong, it is reported to be even higher, 
around 30 %, recently (Lau E.M.C. et al., 1996). Huge amount of health care budget 
is spent by the government on treating vertebral fractures. In US, there are 150,000 
admissions which consume US$ 745 millions annually (Ray N.R et al., 1997). It 
should also be noted that the incidences of vertebral fractures also increase in the 
same trend as that in hip fractures (Cooper C. et al., 1992b). Moreover, the situation 
is even more serious since some of these fractures may have neurological 
complications which result in permanent disabilities. Therefore, the amount spent on 
dealing with osteoporotic vertebral fractures will surely be increased in the future as 
the population ages. 
1.1.3 Difficulties on fixation of osteoporotic bone fracture 
In treating fractures of the bone with poor quality, application of different 
implants like wires or flexible intramedullary nails were not successful because most 
of them are designed for normal bone in young adults but not for the osteoporotic 
elderly. In fact, the use of these implants in the fixation of osteoporotic bone fracture 
often results in "bone failure" where the decrease of bone quality leads to loosening 
of the implants and fixation loss after the operation (Hernefalk L. et al, 1995; Zink 
P.M., 1996; Stromsoe K. et al., 1993). The backing out of the screws even retards 
fracture healing and devascularizes various fracture fragments. 
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1.2 Physiology of osteoporotic bone 
1.2.1 Composition 
Normal bone is made up of an organic component (30 to 40 %) and an 
inorganic (mineral) component (40 to 50 %). The rest 20 % is water. The organic 
component consists primarily of collagen matrix and noncollagenous proteins. Type I 
collagen is the most abundant structural protein in bone cells. It is a helical structure 
composed of three peptide strands help together through collagen crosslinks and 
accounts for more than 95 % of the total volume (Herring G.M., 1972). The 
inorganic component is mainly composed of calcium, phosphate and carbonate (10 : 
6 : 1 ) arranged as crystals predominantly in the form of hydroxyapatite. The mineral 
content of skeleton is stored in both cortical (compact) and cancellous (spongy or 
trabecular) bone. Although there is no significant difference in the composition 
between normal and osteoporotic bone, their architectures are different definitely. 
1.2.2 Architecture 
There are two types of bone tissue, cortical and cancellous. Cortical bone 
appears to be solid but on microscopic examination large numbers of Haversian 
systems can be seen. The Haversian system consists of a central Haversian canal, 
containing blood and lymph vessels and nerves, surrounded by concentric plates of 
bone (lamellae). Between these there are lacunae of spaces, containing lymph vessels 
in the Haversian canal and the osteocytes obtain nourishment from the lymph (Figure 
1.1). This 'tubular' arrangement of lamellae gives bone greater strength than a solid 
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structure of the same size would have. The BMD of cortical bone is much greater 
than that of cancellous bone. Cancellous bone looks like a sponge and with a 
honeycomb appearance. Its BMD is significantly lower when compared with that of 
cortical bone. Microscopically, although the number of lamellae in cancellous bone is 
much fewer than that in cortical bone, its Haversian canals are much larger. Besides, 
red bone marrow is always present in cancellous bone but not in cortical bone. 
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Figure 1.1: Schematic diagram of diaphyseal cortical bone showing the transverse 




In osteoporosis, the BMD of both cortical and cancellous bones will be 
significantly lower than that of normal bone. This phenomenon is especially obvious 
in the cancellous bone in which the number of trabeculae decreases dramatically 
(Figure 1.2). 
A B 
Figure 1.2: Microphotograph showing the difference of normal and osteoporotic 
cancellous bone 
(A): normal cancellous bone with numerous thick trabeculae. (B): osteoporotic cancellous 
bone in which the trabeculae are reduced in volume and number. 
1.2.3 Bone remodelling 
Bone is not an inert tissue. It is estimated that in a mature normal adult, 
approximately 3 % of cortical bone and 25 % of cancellous bone are renewed 
(remodelled) annually (Kanis J.A., 1996; Manolagas S.C. et al., 1995). 
Bone remodelling is a coupled process. The theory of bone remodelling was 
first developed by Frost in 1973 (Frost H.M., 1973). It states that the skeleton 
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remodels in quanta in which the extracellular matrix is sequentially removed and 
replaced by teams of cells called basic multicellular units. This theory is now widely 
accepted and the major events in the bone remodelling cycle are: activation, 
resorption, reversal, formation and quiescence (Frost H.M., 1973; Frost H.M., 1986). 
During the activation, bone surface is converted from a quiescent state to 
one in which circulating mononuclear cells of hematopoietic lineage begin to 
congregate and fuse together to form differentiated osteoclasts. Activation is 
followed by resorption. In which, a team of osteoclasts dissolves the mineral 
component of bone and hydrolyzes the organic matrix, results in excavating a cavity 
on the bony surface. 
Reversal phase is a transition period during which formation is coupled to 
resorption and characterized by the presence of preosteoblasts. The last phase of the 
remodelling cycling is formation. At first, osteoblasts differentiate in the reversal 
lacuna. Laying down unmineralized organic matrix (osteoid), they refill the 
excavation site by forming the new basic structural unit or osteon. 
Bone formation (the amount of bone fill) and bone resorption (the amount 
of bone resorbed) are the deterministic processes during bone remodelling. In normal 
condition, the formation rate equals to the resorption rate, with no net change in the 
volume of bone (Manolagas S.C. et al., 1995). Nevertheless, once imbalance 
between formation rate and resorption rate occurs, bone metabolic diseases result. 
Osteoporosis is one of the diseases in which the bone resorption rate is faster and 




1.3 Method to develop osteoporotic animal models 
1.3.1 Requirements for an ideal animal model 
The advantages of an animal model are obvious, but the selection of a 
suitable one is more difficult. Several factors must be considered when discussing 
possible models for osteoporosis, and these are well defined by Rodgers and her 
group (Rodgers J.B. et al., 1993) and others (1981) as "convenience, relevance 
(comparability to the human condition), and appropriateness". Besides, the following 
elements should also be put into consideration during the selection of an appropriate 
animal model for research: 1) transferability of information, 2) genetic uniformity of 
organisms where applicable, 3) background knowledge of biological properties, 4) 
cost and availability, 5) generalizability of the results, 6) ease and adaptability to 
experimental manipulation, 7) ecological considerations, and 8) ethical and societal 
implications (Davidson M.K. et al., 1987). It is apparent that most of the animal 
models used for the study of osteoporosis meet some, but certainly not all, of these 
elements. 
1.3.2 Common animal models 
1.3.2.1 Rodents, guinea pigs and rabbits 
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Laboratory animals including rodents, guinea pigs and rabbits are the most 
popular animal models in scientific and medical researches. They are inexpensive 
and easy to house. Genetically specific strains can be acquired and their shorter life 
span enables studies on the effects of aging on the bone. There is little doubt that the 
most commonly used animal model for osteoporosis studies is the rodent. Extensive 
literature studying the ovariectomized rat including the histomorphometric changes, 
biochemical markers, methodology for bone densitometry, and evaluation of bone 
fragility has been published (Wronski T.J. et al., 1991; Frost H.M. et al., 1992; Kalu 
D.N., 1991). On the contrary, although guinea pigs, have a long cycle, ovulate 
spontaneously, and have an active secreting corpus luteum, ovariectomized adult 
guinea pigs showed no effect on bone volume (Vanderschueren D. et al., 1992). On 
the other hand, even though there are very few studies using ovariectomized rabbit to 
study osteoporosis, rabbits achieve skeletal maturity shortly after reaching complete 
sexual development (Gilsanz V. et al., 1988), and thus should be one of the potential 
animal models for studying osteoporosis. 
No matter whether or not these laboratory animals can be used for 
osteoporosis study, their small body size prevents both large blood or bone sampling. 
Longitudinal studies cannot be preformed if repetitive bone sampling and large blood 
samples are required. Moreover, their small bone size also restricts their use as a 
model for studying osteoporotic fracture fixation, in which large metallic implants 
are commonly applied. Large animal models are therefore needed. 
1.3.2.2 Non-human primates 
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Non-human primates such as baboons and macaques demonstrate many 
advantages over other models for osteoporosis. Their organ systems including 
gastrointestinal tract, endocrine system, and bone metabolism closely resemble the 
human systems. In fact, an abundance of literature documents the skeletal effects of 
ovariectomy on old-world monkeys (Miller L.C. et al., 1986; Young D.R. et al., 
1986; Longcope C. et al., 1989). They reported that there was a significant reduction 
in vertebral cancellous bone volume after ovariectomy of the female monkey. 
However, acquisition of female primates is difficult and very costly. Furthermore, 
they are aggressive, and more seriously, Newman et al in 1995 stated that the risk of 
zoonotic disease transmission, including HIV, from these animals is relatively high. 
The handling of these animals becomes an issue of concern. 
1.3.2.3 Dogs and pigs 
Domestic animals are also good choices. The most obvious advantage of 
dogs in the study of osteoporosis is that they possess Haversian systems of cortical 
.bone, the internal bone remodelling of cortical and cancellous bone is similar to that 
of the human. Besides, they are less expensive than the primate and easier to work 
with. 
However, some studies have shown insignificant bone loss in dogs after 
cessation of ovarian function (Kimmel D.B., 1991; Shen V. et al., 1992) due to their 
relatively low levels of estrogen and the semiannual estrus cycle. Dogs give rise to 
handling problems too because they are aggressive as non-human primates especially 
when housed together in a small space. Sample size of the study is therefore 
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restricted when osteoporotic researches are conducted in Hong Kong. Some 
researchers pointed out that due to their pet-status, dogs are less acceptable by the 
society as an animal model for scientific or pre-clinical research (Newman E. et al., 
1995). 
Farm pig seems can be another potential choice as their continuous 
reproductive cycle and the length of each cycle is similar to that of human. They are 
large enough to receive prosthetic implants and can withstand repetitive bone 
biopsies and large volume blood sampling. Nonetheless, housing and handling are 
difficult as pigs are noisy and can be aggressive. Importantly, ovariectomy is difficult 
on pigs because the blood supply to their uterus is more friable. 
1.3.2.4 Sheep and goats 
Sheep or goats often serve as models for human conditions. Most recently, 
many in vivo (Osti O.L. et al., 1990; Gunzburg R. et al., 1993) or in vitro (Nagel 
D.A. et al., 1991; Vazquez-Seoane P. et al., 1993) experimental studies used sheep 
spine as model for BMD analysis and mechanical tests. There was report stated that 
sheep and human vertebra were very similar in the thoracic and lumbar regions 
anatomically and biomechanically, although they did show substantial difference in 
certain dimension (Wilke H.J. et al., 1998). Morphological variation as a function of 
spine level was well matched in the two species. They concluded that the sheep spine 
might not only be useful as a model for disc operations or bone healing processes but 
might also serve as an alternative for the evaluation of spinal implants. Besides, a 
resemblance between the iliac crest of the sheep and the human has been reported 
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(Pastoureau P.D. et al., 1989; Turner A.S. et al., 1993a). In addition, it has been 
reported that the hormonal profiles of ewe were similar to that of women (Goodman 
R.L., 1994). 
Sheep and goats are docile and compliant flock animals that they can be 
handled easily. They suffer the least stress when housed in groups when compared 
with the large animals mentioned previously. It is undoubted that their large body 
size enables studies of implant fixations and they can withstand repetitive bone 
biopsies and large volume blood sampling for longitudinal studies. Recently, the use 
of ewe as a model for osteoporosis research has been reported not only successful but 
also promising (Turner A.S. et al., 1995; Pastoureau RD. et al., 1989; Turner A.S. et 
al., 1993a; Turner A.S. et al., 1995; Turner A.S. et al., 1993b; Hornby S.B. et al., 
1995). However, area with hot and humid climate, such as Hong Kong, is unsuitable 
for keeping of sheep. 
Up till now, goat has not yet been reported as either a successful 
osteoporotic or osteopenic animal model. Therefore, female Chinese mountain goats 
were selected in the present study. 
1.3.3 Ovariectomy 
Ovary is a female sex organ from where several sex hormones are released. 
One of the hormones is estrogen that is critical in the acquisition of bone mass and in 
maintaining calcium homeostasis (Albright R, 1941). 
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Estrogens can be divided into two types: steroidal and nonsteroidal. Each 
can be further subdivided into natural and synthetic estrogens. Only the steroidal 
natural estrogens are concerned in discussing the relationship between estrogens and 
osteoporosis in this study. There are three classic steroidal natural estrogens. The 
major one is estradiol, the other two being estrone and estriol (Figure 1.3). Except 
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secreted from ovaries, a small amount of estrogen is produced in the testis and some 
by peripheral conversion from circulating testosterone. 
Figure 1.3: Chemical structures of estrone, estradiol and estriol. 
(from Estrogens and Progestogens in Clinical Practice. Fraser I.S. et al) 
Estrogen affects bone remodelling in both direct and indirect ways: Directly, 
estrogen regulates bone remodelling by expressing its effect through binding to the 
estrogen receptors in both osteoclasts and osteoblasts. Although the mechanism 
remains unknown, estrogen decreases the activities of osteoclasts on bone resorbing 
surface (Parfitt A.M., 1979). One possibility is that estrogen deficiency increases 
osteoclast life span because it has been proved that the presence of estrogen enhances 
programmed cell death in osteoclasts. However, once it has been withdrawn, 
osteoclast apoptosis is reduced and osteoclasts live longer (Hughes D.E. et al., 1996). 
Furthermore, not only reduces bone resorption and lysosomal proteinase secretion of 
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osteoclasts (Oursler M.J. et al., 1994; Oursler M.J. et al, 1993; Pederson L. et al., 
.1997), estrogen also suppresses their formation (Manolagas S.C. et al., 1993; Kaji H. 
et al” 1996). On the other hand, estrogen increases the type I collagen synthesis and 
secretion (Komm B.S. et al., 1998; Benz D.J. et al., 1991) as well as the 
differentiation of stromal cells into osteoblasts. 
Indirectly, estrogen also acts as an inhibitor to interleukin-1 (IL-1), 
interleukin-6 (IL-6) and also tumor necrosis factor (TNF) (Jilka R.L. et al., 1992; 
Kimble R.B. et al., 1994; Kitazawa R. et al., 1994). IL-1, IL-6 and TNF are 
cytokines known as potent stimulators of osteoclastogenesis and bone resorption. 
The withdrawal of estrogens in experimental animals and human leads to an 
immediate upregulation of the synthesis of the osteoclast-supporting cytokines 
synthesis in bone marrow stromal and osteoblastic cells (Manolagas S.C. et al., 1995; 
Jacobsen S.J. et al., 1990) (Figure 1.4). 
Ovariectomy, also called oophorectomy, is a surgical operation to excise the 
ovaries from female. In 1940s, Fuller Albright highlighted the importance of sex 
steroids in a series of elegant clinical descriptions (Albright F. et al., 1940; Albright 
F.，1947). He pointed out that the prevalence of ovariectomy among osteoporotic 
patients was higher than expected. Also, almost invariably among these patients, the 
surgery had been performed at an age younger than the average age of the natural 
menopause. Natural cessation of estrogen production in middle life also triggers bone 
loss, and finally leads to osteoporosis. There are reports illustrating that osteoporosis 
typically affects women within 15 to 20 years after menopause (1990; Riggs B.L. et 
al., 1986). Furthermore, it is easy to understand that among the elderly, female 
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suffers more from osteoporosis (1990; Singer B.R. et al., 1998). It is estimated that 
about 30% of postmenopausal women are affected by osteoporosis although there 
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Figure 1.4: Drawings showing the effect of estrogen (E2) on the balance and 
imbalance bone remodel l ing 
At normal levels, E2 regulates osteoclastic bone resorption by modelling the differentiation 
and activation of osteoclasts via inhibition of osteoblast and monocyte-derived cytokines and 
stimulation factors (IL-1, 1L6 and TNF), results in bone formation equal to bone resorption. 
The 丨OSS of E2 regulation results in unopposed secretion of cytokines and stimulation factors, 




may be some racial differences (Or H.Z. et al., 1999; Kan is J.A. et al., 1999; Melton 
III L.J., 1995). Ovariectomy has been recognized as a well-established method to 
induce osteoporosis in animals. It was reported successful in rat (Wronski T.J. et al., 
1989; Wronski T.J. et al., 1991; Frost K M . et al., 1992; Kalu D.N., 1991), rabbit 
(Gilsanz V. et al., 1988), sheep (Turner A.S. et al., 1995; Pastoureau RD. et al., 1989; 
Turner A.S. et al； 1995; Turner A.S. et al., 1993b; Hornby SB. et al., 1995) and 
monkey (Miller L.C. et al., 1986; Longcope C. et al., 1989). 
1.3.4 Restricted calcium diet 
Calcium is one of the nutrients playing an important role in bone 
metabolism. The skeletal content of elemental calcium at birth increases 40-fold by 
the time skeletal maturity is reached. Thus, it is clear that without calcium there 
would be no skeleton - or at least it would not be mineralized. The amount of 
calcium acquired from diet is therefore being concerned. There is considerable 
evidence, accumulated over the past several decades form cross-sectional (Matkvoic 
V. et al., 1979; Sentipal J.M. et al., 1991), longitudinal (Dawson-Hughes B. et al, 
1987) and intervention studies (Smith E.L. et al., 1989) indicating that dietary 
calcium intake is an important determinant of bone mass. It has also been reported in 
some population-based studies that the skeletons of the people with high calcium 
intakes are heavier than those with low calcium intakes. Some studies even reported 
an impressive observation that the population with higher calcium intakes has a 
substantially lower fracture rates (Matkvoic V. et al., 1979). Higher intakes are 
especially recommended in adolescence and pregnancy. 
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Changes in the dietary intake of calcium are capable of inducing changes in 
the rate of bone turnover. For a healthy adult having an inadequate dietary intake of 
calcium, the bone turnover rate is increased. The mechanism behind is related to 
hormonal changes in calcium metabolism. During calcium depletion, serum calcium 
level tends to fall, which stimulates the secretion of PTH and the synthesis of 
calcitriol, which in turn increase the activation of bone remodelling and induce a 
decrease in bone mass. 
Since estrogen deficiency induces a focal imbalance at remodelling sites, 
metabolic changes which increase the remodelling rate of bone will accelerate 
skeletal losses even further. Therefore, it is not uncommon that restricted or low 
calcium diet is introduced together with ovariectomy in order to develop an 
osteoporotic animal (Yoshida Y. et al., 1998; Jiang Y. et al, 1997). 
1.4 Assessment of osteoporosis development 
1.4.1 Photodensitometry 
Clinically, radiography is commonly adopted by clinicians for assessment of 
bone quality of patients. However, for evaluation of bone mass quantitatively, 
conventional radiography is relatively insensitive since bone loss is only apparent 
when mass has decreased by about 30 - 50% (Ruegsegger P., 1996). Notwithstanding 
its insensitivity, there are distinctive radiographic morphometric features of bone that 




Photodensitometric techniques have been applied on X-rays films to 
measure the optical density of bone. Metacarpal and the distal radius are the 
commonest sites for measurement in human. A reference step wedge is placed 
alongside the area of interest and the results are usually expressed as an equivalent 
thickness of the wedge material. It has a reasonable accuracy and there is a close 
correlation between measured values and bone ash. With computer-assisted 
techniques, its value is further increased. 
1.4.2 Bone densitometry by using Peripheral Quantitative Computed Tomography 
(pQCT) 
Since many studies have demonstrated that the decline in BMD can indicate 
an increase in the risk of fractures (Hui S.L. et al., 1988; Wasnich R.D. et al.,； 
Gardsell P. et al., 1991), measurement of BMD has become the reference in clinical 
practice for evaluating osteoporosis. Although Dual Energy X-ray absortiometry 
(DEXA) and Peripheral Quantitative Computed Tomography (pQCT) are the two 
main techniques currently used for the measurement of bone mass in both clinical 
and research settings, the later permits a separate assessment of cancellous and 
cortical bone. Furthermore, it is unaffected by the superposed tissue when compared 
with DEXA. 
Traditional measurement of BMD using absorptiometry encounters a 
problem of only getting the planar information of bone density. The quantitative 
computed tomography (QCT) can solve this problem. Both axial QCT and peripheral 
QCT are now applied for the quantitative measurement of bone density. In which, 
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pQCT was specifically developed for bone evaluation. pQCT is a useful technique to 
perform precise bone density determinations and high resolution images for 
structural analysis. It can provide the information of the bone status in the extremities 
since a small change can be detected after therapy (Ruegsegger P. et al., 1976; 
Ruegsegger P., 1990). When compared with axial QCT, pQCT has an advantage of 
generating low radiation dose and guarantees a high reproducibility by measuring the 
same site in the follow-up studies. 
During the measurement, the specimens are placed in custom-made 
radiolucent casts to ensure that the CT scans are always made at an identical angle 
relative to the bone axis. Then, a scout view is taken to define the region to be 
scanned. In addition, a stack of continuous thin-slice tomograms of the region of 
interest can be obtained. Same pattern of the region of interest can be recognized 
automatically to ensure the same bone volume is analyzed on repeated 
measurements. The long-term reproducibility of it is 0.3% in in vivo studies 
(Ruegsegger P. et al., 1976). Among those available pQCT devices, Densciscan® has 
the best precision compared to the other systems (Schneider P. et al., 1996) and was 
used in this study. 
Because of its high precision, pQCT becomes particularly suitable for serial 
examinations. A study showed that the losing rate of the cancellous bone of the 
radius for the postmenopausal women is 3 % per year. Therefore, BMD measurement 
using pQCT not only can identify the high bone loss after menopause (Ruegsegger P. 
et al., 1976), but also can detect very small changes in the trabecular bone density. In 
other words, it can be applied to investigate the change of bone mineral density in a 
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short period after therapeutic intervention (Dambacher M.A. et aL, 1998; Dambacher 
M.A. et aL, 1986), even within a few months (Dambacher M.A. et aL, 1998; Langton 
C M . et aL, 1984). 
Moreover, pQCT can be regarded as a technique complementary to static 
and dynamic histomorphometry. As it can provide three-dimensional information 
about the architecture of bone, it can be applied to estimate the bone mechanical 
properties (Faulkner K.G. et aL). 
1.4.3 Biomechanics of osteoporotic bone 
Osteoporosis is characterized by the decreased bone mass and increased 
susceptibility to fracture in an aged individual. Fracture represents a structural failure 
of bone which is related not only to its capacity to carry load, but also on the forces 
that are applied to its structure during service (Hayes W.C., 1991; Hayes W.C. et aL, 
1991). The mechanics of fracture in both cortical and cancellous bone can be 
characterized by the failure strength - the maximum stress in a material under given 
loading conditions that often coincides with rupture. Bone strength is related to bone 
density, architecture, connectivity and mineralization. The bone density alone 
accounts for approximately 75 to 80 % of the variance in the bone strength (Keaveny 
T. et aL, 1993; Einhorn T., 1992). In osteoporosis, the mechanical consequences of 




1.4.3.1 Screw pullout test 
The material properties of both cortical and cancellous bone decrease with 
increasing age, reflecting changes in bone density and microstructural arrangement. 
There was report stating that the tensile strength of cortical bone declines by about 2 
% per decade over the age range of 20 to 90 (Burstein A.H. et al., 1976). Moreover, 
owing to the increase in porosity in osteoporotic bone, the use of implants in the 
fixation of osteoporotic bone fracture often results in "bone failure", leading to 
loosening of the implants and fixation loss after the operation (Hernefalk L. et al., 
1995; Zink P.M., 1996). Stromsoe found that pullout force in osteoporotic bone was 
smaller when compared with that from normal bone (Stromsoe K. et al., 1993). Soshi 
also reported that screw pullout force from osteoporotic bone diminished with 
osteoporosis severity (Soshi S. et al., 1991). Owing to the decrease in number and 
size of the trabeculae in osteoporotic bone, the difference of the pullout forces 
between osteoporotic and normal bone in the cancellous region should be even more 
obvious. Screw pullout force, as expected, is a characteristic showing the difference 
between osteoporotic bone and normal bone. 
1.4.3.2 Indentation test 
Trabecular tissue exhibits large age-related decline in failure strength. Its 
compressive strength has been found to decrease by more than 10 % per decade 
(Mosekilde L. et al., 1987). This decline in strength is in part a reflection of the 
decrease in bone apparent density (wet weight of the specimen divided by the total 
specimen volume) with age in osteoporosis. The compressive strength of human 
22 
Introduction 
cancellous bone is related to the bone apparent density by a power-law relationship. 
Even small changes in density can be translated into major changes in bone strength 
(Keaveny T. et al” 1992; Gibson L.J. et al., 1988). Hence, indentation test, which is a 
simple compression test, on cancellous bone can be used to distinguish osteoporotic 
bone from normal one. 
Bone does not behave as a perfect spring. There are viscous effects which 
cause some of the elastic energy to be lost. In order to yield a fully linear elastic 
behavior, uniaxial compressive indentation test was chosen and performed at slow 
strain rate (Keaveny T.M. et al., 1994). 
1.4.4 Biochemical markers of bone turnover 
Invasive methods for the evaluation of bone turnover, such as 
histomorphometry and calcium kinetic studies, although are valuable in diagnosing 
certain metabolic bone disorders, are not suitable for longitudinal follow-up. 
Moreover, histomorphometric analysis provides only the changes of bone turnover at 
a specific site. This leads to an intensive search for non-invasive methods to measure 
the total skeletal bone turnover and bone mass (Nilsson B.E. et al., 1990). 
Measurement of biochemical markers is one of the choices. It is non-invasive, and 
more sensitive that it can detect changes of bone turnover in a short interval of time 
(RiggsB.L. et al., 1995). 
Bone remodelling is a continuous and dynamic process of renewal, whereby 
a quantum of new bone is reformed following dissolution. During bone resorption, 
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calcium and other matrix constituents are released into the bloodstream where they 
are metabolized or excreted. As bone formation proceeds, skeletal-specific proteins 
(enzymes or matrix components) can leach into the circulation in relatively high 
concentrations, permitting measurement by various techniques. Assays for 
biochemical markers of bone remodelling are well developed (Table 1.1) and these 
measurements have been shown to correlate with dynamic studies of calcium 
kinetics. 
Markers of bone formation Markers of bone resorption 
Serum Urine Serum 
Alkaline phosphatase (ALP) Calcium Cross-linked carboxyterminal 
telopeptide type I collagen 
(CTx) 
Bone-specific alkaline Hydroxyproline 
phosphatase (BALP) 
Osteocalcin (OC) Pyridinoline and 
deoxypyridinoline 
Procollagen I C-terminal Cross-linked aminoterminal 
extension peptide (PICP) telopeptide type I collagen 
(NTx) 
Table 1.1: Biochemical markers of bone metabol ism 
1.4.4.1 Bone formation markers 
Biochemical markers of bone formation have been used for many years in 
the detection of metabolic bone disease. In general, markers of bone formation 
reflect osteoblastic function. During stages of osteoblast differentiation, collagen 
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metabolites are expressed first, followed by osteocalcin, and then alkaline 
phosphatase. Therefore, it would be expected that the earlier the expression of the 
markers in the differentiation process, the more sensitive they are as the indicator of 
bone formation (Stein G.S. et al., 1993). Among these markers, bone-specific 
alkaline phosphatase and osteocalcin are widely used clinically in the monitoring of 
bone remodelling. 
1.4.4.1.1 Bone-specific Alkaline Phosphatase (BALP) 
Alkaline phosphatases (ALP) are glycoproteins that are encoded by at least 
four gene loci. In human serum, tissue-nonspecific (liver, bone and kidney), 
intestinal and placental ALPs have been identified (Seargeant L.E. et al., 1979; 
Harris H., 1989). Although the isoenzymes from liver, bone, and kidney are products 
of the same gene (Weiss M.J. et al., 1986), they differ from each other on the basis of 
their electrophoretic mobilities, heat and urea stabilities and their capacities to 
interact with lectins (Garnero P. et al., 1993; Farley J.R. et al., 1981; Rosalki S.B. et 
al, 1984). 
Bone-specific ALP (BALP) is a tetrameric ecto-enzyme (localizes in the 
plasma membrane) produced by osteoblasts and is released into the circulation as a 
dimmer by phospholipase cleavage of a membrane-anchoring 
phosphatidylinositolglycan moiety that is attached to the carboxyl-terminus of the 
protein (Howard A.D. et al., 1987). Although the function of BALP is unknown, the 
enzyme is thought to be involved in bone formation and skeletal mineralization in 
vivo (Fishman W.H., 1990; Rodan G.A. et al., 1982; McComb R.B. et al, 1979). 
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Although total ALP (TALP) activity in serum is commonly used as a marker of bone 
turnover, many sources other than bone may contribute to the total enzymatic activity 
present in serum (Delmas P.D., 1995). TALP in serum is therefore considered a 
nonspecific, relatively insensitive marker of bone metabolism (Delmas RD., 1995; 
Moss D.W., 1982). BALP, on the other hand, has been proved to be more sensitive 
than TALP in monitoring patients with osteoporosis (Garnero R et al., 1993; Stephan 
J. et al, 1978; Farley J.R. et al, 1981). 
In this study, wheat germ lectin (WGL) precipitation assay is used to 
determine the activity of BALP. The assay was firstly described by Rosalki and Foo 
in 1984 (Rosalki S.B. et al., 1984). It required two-step incubation with a pre-
treatment of Triton X-100. However, the pre-incubation was time consuming and 
caused complication during the calculation of BALP activity. After 2 years, Rosalki 
and Foo modified the method to only one-step incubation that was necessary for 
BALP precipitation (Rosalki S.B. et al., 1986). The modified method was also 
adopted in our department in previous studies by using ABBOTT VP system and A-
gent® (Liu P.P. et al., 1996; Leung K.S. et al., 1993). 
1.4.4.1.2 Osteocalcin (OC) 
OC, also called bone gla protein (BGP), is found exclusively in bone tissue. 
It is a 5800 molecular weight extrahepatic vitamin K dependent protein produced 
primarily by osteoblasts (Nishimoto S.K. et al., 1979). It contains three gamma-
carboxyglutamic acid residues which are thought to be involved in calcium ion and 
hydroxyapatite binding. It accounts for 10 to 20 % of the noncollagenous protein in 
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bone. While the in vivo function of OC is unknown, its affinity for bone mineral 
constituents implies a role in bone formation (Akesson K., 1995; Price P.A. et al., 
1981) and bone mineralization (Lian J.B. et al., 1982). Most of the newly 
synthesized OC is immediately bound to the bone mineral, with only a proportion 
being secreted directly into the blood. The serum concentration of OC has been 
demonstrated to be the first specific biochemical marker of bone formation and 
correlated well with histomorphometric and calcium kinetic measurement of bone 
formation (Delmas RD. et al” 1985; Brixen K. et al., 1989). 
Following the development of the first immunoassay in 1980 (Price P.A. et 
al., 1980), various forms of assays for serum OC have been used extensively. An 
ELISA immunoassay was used in this study to measure the serum OC concentration 
in goats. The assay makes use of a mouse antiosteocalcin antibody, an anti-mouse 
IgG-alkaline phosphatase conjugate and a a-Nitrophenly phosphate substrate to 
quantitate the OC in serum. 
1.4.4.2 Bone resorption markers 
Bone is composed of a mineral or an inorganic component (calcium 
hydroxy apatite) and an organic or protein matrix. The organic matrix is composed 
primarily of collagen and more than 95 % of which is Type I collagen (Herring G.M., 
1972). Therefore, the degradation of Type I collagen provides information about 
bone resorption. Calcium, hydroxyproline, amino (N-) or carboxy (C-) terminal 
collagen telopeptides (Tx) as well as collagen crosslinks including pyridinoline (Pyd) 
and deoxypyridinoline (Dpd) are excreted in urine upon the degradation of Type I 
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collagen, and hence are commonly used as bone resorption markers. 
Both serum or urinary calcium and urinary hydroxyproline are not good 
bone resorption markers because their levels are influenced by other factors 
(Akesson K., 1995; Marie-Christine de Vernejoul, 1998; Bikle D.D., 1997; 
Concepcion de la Piedra et aL, 1997). Pyd, on the other hand, is present in cartilage 
and other tissues and hence is also non-specific (Riis B.J., 1991; Concepcion de la 
Piedra et aL, 1997; Withold W. et aL, 1995; Cloos C. et al., 1998). Although NTx is 
well accepted as a specific bone resorption marker (Hanson D.A. et al., 1992), its 
specificity is still lower than that of CTx and Dpd (Concepcion de la Piedra et al., 
1997). In the present study, Dpd is used because it is the most commonly used 
marker. 
1.4.4.2.1 Deoxypyridinoline (Dpd) 
Both Dpd and Pyd are the pyridinium crosslinks of Type I collagen in bone 
matrix (Seyedin S.M. et al., 1990; Delmas P.D., 1995). In human bone, the ratio of 
Pyd / Dpd is approximately 2:3 (Eyre D., 1992). During bone resorption, the 
breakdown of these crosslinks by the enzymatic action of lysyl oxidase on the amino 
acid lysine guarantees their presence in the circulation (Seibel M.J. et al., 1992; 
Delmas RD. et aL, 1991; Eastell R. et al., 1997). They are then excreted via the 
kidney with 40 % in free form and 60 % in peptide-bound form (Akesson K.，1995; 
Marie-Christine de Vernejoul, 1998). All pyridinium crosslinks are not influenced by 
diet and are not metabolized in the circulation. However, formed from two 
hydroxylysine residues and one lysine residue, Dpd is found exclusively in bone and 
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dentin. It was reported that creatinine standardized urinary free Dpd sensitivity reach 
79 % with a specificity of 100 % (Concepcion de la Piedra et al., 1997). The urinary 
Dpd concentration therefore highly represents the rate of bone resorption. 
In the past, high performance liquid chromatography (HPLC) was used to 
measure the concentration of Dpd. However, this method is time consuming and 
tedious. This assay involves a rather laborious multi-step procedure of acid 
hydrolysis, extraction, and then HPLC. Besides, the crosslinks recovery by HPLC 
may be incomplete. Recently, the Food and Drug Administration (FDA) has proved 
an effective, simple, antibody-linked urinary immunoassay (ELISA) for Dpd as a 
biochemical marker for bone metabolism. For the assay, a monoclonal antibody 
recognizing free Dpd is employed for quantitating of Dpd concentration in the urine 
sample (Robins S.R et al., 1994). 
1.4.4.2.2 Creatinine 
Creatinine is the anhydride of creatine. Between 1 and 2 % or free creatine 
in muscle is spontaneously converted to creatinine daily. The amount of endogenous 
creatinine produced is proportional to muscle mass and is released into body fluid at 
a constant rate (Whetlon A. et al., 1996). Urinary creatinine excretion was first 
proposed as an index of the accurate collection of a 24-hour urine sample by Folin in 
1905 (Folin O., 1905). The daily excretion of creatinine is independent of urine 
volume (Wang E., 1939), and is only slightly increased by physical exertion (Van 
Pilsum J.F. et al, 1958). Although it can be higher as a result of dietary intake of 
creatine and creatinine in meat (Vestergaard P. et al., 1958), the intake causes only 
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slight variation in daily creatinine excretion. Moreover, goats are herbivores, even 
this minor variation is absent in this study. 
Determination of creatinine has been widely used for checking the 
completeness of 24-hour urine sample. Moreover, urine measurement must be 
normalized with creatinine, a measurement with its own error of determination 
(Bikle D.D., 1997). Current methods are mostly based on the Jaffe reaction described 
in 1886 (Jaffe M.Z., 1886). In which, creatinine reacts with alkaline picrate to form 
an orange-red complex. The amount of the colored complex formed is directly 
proportional to the concentration of creatinine in urine sample. 
1.5 Objectives 
The treatment of osteoporosis and its associated fractures are key research 
areas nowadays. Although the best defense against the disease is prevention, there is 
also a great need for treatment of those with established osteoporosis. Recently, the 
use of ewe as a model for osteoporosis research has been reported not only 
successful but also promising (Pastoureau P.D. et al,, 1989). However, sheep is 
unavailable in Hong Kong where the hot and humid climate is also unsuitable for 
their living. On the other hand, there is no related research on female goats. 
Quantitative biochemical and biomechanical parameters, bone mineral density 
(BMD), and histomorphometric data of goats are still lacking. 
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In the present study, we aimed: 
(1) understand the behavior and living style of goats 
(2) establish a large animal model for osteoporotic human 
(3) identify the most reliable parameters for assessment of osteopenia in 
goats 
Goats were subjected to ovariectomy. The development of osteoporosis was 
monitored and assessed monthly by photodensitometry, biochemical markers 
including BALP, Dpd and OC. BMD of iliac crest biopsy were also measured before 
the operations (either ovariectomy or sham operation) as well as six months after the 
operations. On the other hand, biomechanical parameters obtained from screw 
pullout test and indentation test of the autopsies of the ovariectomized and shammed 
groups were compared after euthanasia. 
Results obtained form this project can: 
(1) provide information in new implant design 
(2) provide an in vivo model for testing different implanted biomaterials 
(3) provide information on the usefulness of the spine of goat as a model for 
bone healing and implant fixation 





Chapter 2: Methodology 
2.1 Establishment of osteoporotic animal model 
2.1.1 Animal arrangement 
Twenty-nine female Chinese mountain goats were purchased from the 
government slaughterhouse in Kinnedy Town in Hong Kong. All the goats were 
imported from Mainland China. Their weights were between 22 to 28 kg with an 
average 25 kg (Figure 2.1). Their transfer to The Chinese University of Hong Kong 
(CUHK) was under the permission from the Hong Kong Agriculture and Fishery 
Department. 
The goats were penned in the air-conditioned and dark-light cycle controlled 
Animal House of the Laboratory Animal Services Center in the CUHK. All were fed 
with Lucerne Chaff in the first week and then gradually mixed with the commercial 
ruminant diet {Glen Forrest Stockfeeders, Australia) up to a half-and-half ratio. The 
animals were cared by qualified veterinarian during the whole study. 
The project was separated into two parts. In Part I, skeletally mature goats 
were used. Their maturity was guaranteed by the absence of growth plate in their 
proximal tibiae under the X-ray assessment. They were divided into Ovariectomy 
(Ovx) group or Sham Control (Sham) group randomly before the respective 
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operation. In Part II, goats were about two years old and were skeletally immature. 
Growth plates in proximal tibiae were still present under the examination by X-ray. 
They were also randomly separated into two main groups before the operation: Ovx 
group or Sham group. 
All the goats were allowed at least seven days for adapting to the new 
environment before operation after their arrival. The goats in Ovx group were 
ovariectomized bilaterally under standardized aseptic surgical technique. Same 
surgical procedure was followed on the Sham group except the ligation of oviducts 
and the excision of ovaries. 
nil 




The goat was fasted for one day before the operation. It was placed in left 
recumbency on an operation table with surgical side facing upward. The goat was 
anesthetized via inhalation of 5 % halothane (Fluothane ™ Zeneca, Cheshire, UK), 
together with a mixture of nitrous oxide (1 L/min) and oxygen (2 L/min), until it was 
unconscious and its corneal reflex was inhibited. Anesthesia was maintained by 
intubation with a 7.0 or 7.5 endotracheal tube by using a laryngoscope. Its breathing 
pattern was monitored using an electronic respiration monitor (apAlert RMS, 
Provet®, Australia) throughout the whole operation. A nasogastric tube was also 
introduced through the nostril to drain the excessive fluid from the rumen and to 
prevent the development of mminal tympany. 
Hair of the left lumbar region of the goat was shaved using an electric 
clipper {Oster Golden A5). Skin was cleaned with soap water to clear the hair debris 
and sterilized with 75 % ethanoL Sterilized drapes were fixed to cover the body of 
the goat exposing only the operation site. 
A 10-cm incision was made over flank. After the external and internal 
abdominal oblique as well as the transversus abdominis were dissected and retracted, 
peritoneum was exposed. Incising the peritoneum, ovary and suspensory ligament 
were then exposed underneath (Figure 2.2). After ligating the ovary arteries, the 
ovaries were excised bilaterally from the suspensory ligaments, followed by suturing 
the peritoneum and abdominal muscles in layer with simple continuous method. 
32 
Methodology 
Finally, the wound was closed. 
Figure 2.2: Ovariectomy 
Horns of uterus (long and curve) and both left and right ovaries (within the white 
circles) were exposed after the transversus abdominis had been dissected and 
retracted followed by incision of the peritoneum. 
The removed ovaries were immersed and fixed in 0.9 % formalin 
immediately for histological confirmation. Oxygen was given to the goat for one 
minute for accelerating its recovery. Two infrared lamps {infraphil HP3616, Philips, 
Hong Kong) were also used for keeping the goat warm before it recovered 
completely. 
Subcutaneous antibiotics {Amoxicilline, 10 mg/kg, AlfaMedic Ltd. Hong 
Kong) and intramuscular analgesic (Temgesic®’ 0.5 ml every 6 hours, Reckitt & 
Colman Products Ltd., Hull, Britain) injections were applied to prevent wound 
inflammation and to reduce pain respectively. 
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2.1.3 Restricted calcium diet 
The ovariectomized skeletal mature goats in Part I were fed with low 
calcium diet after the operation (50% of food pellet with 0.2 % calcium, produced by 
Glen Forrest Stockfeeders, Australia., plus 50 % Wheaten Chaff with 0.3 % calcium, 
from O'Driscoll, Australia). The goats of the Sham group were fed with normal diet 
containing 1.1 % calcium on average (50 % food pellet with 0.85 % calcium, from 
Glen Forrest Stockfeeders, Australia-, plus 50 % Lucerne Chaff, from Southern Cross 
Grains Pty. Ltd., Victoria, Australia). 
2.1.4 Confirmation of successful ovariectomy 
2.1.4.1 Histological assessment 
The ovary was fixed in 0.9 % formalin for 1 day. It was then placed into a 
tissue processor (Histokinette 2000, South East Chemicals and Instruments Ltd. 
Hong Kong) for paraffin embedding. The embedded specimen of ovary was serial 
sectioned at 10 jim thickness using microtome {South East Chemicals and 
Instruments Ltd. Hong Kong), stained with haematoxylin and eosin (H&E) (Wheater 
RR. et al., 1987) and observed under light microscope {DMLS, Leica, Hong Kong). 
Ovariectomy was confirmed to be successful from the observation. 
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2.1.4.2 Biochemcial assessment 
Estradiol-17(3 (E2) is a C-18 steroid hormone produced mainly by the 
Graafian follicle of the ovary and placenta in female. Small amount was also 
produced by adrenals and testes in male subjects. In non-pregnant women, there are 
cyclic fluctuations in the concentration of E2, the highest value being measured 
usually the day before ovulation. E2 regulates the level of luteinizing hormone (LH) 
and its increase is important for elevating the concentration of LH and hence 
ovulation. In post-menopausal women, serum E2 concentrations are very low. Serum 
E2 level was thus used as an index of the function of the ovary. 
The change of serum E2 level was monitored by an ELISA kit 
(FERTIGENIX E2-EASIA, Bio Source Europe S.A., HealthCare Diagnostics Ltd, 
Hong Kong). Blood was collected before the operation (Ovx / Sham) as baseline and 
monthly after the operation. Blood collection was performed in the morning in order 
to minimize diurnal effect. Serum was obtained after centrifugation of the blood 
samples using a centrifuge setting at 3000 rpm and 4 °C for 10 minutes. {lEC 
.CENTERA-GPS, South East Chemicals and Instruments Ltd. Hong Kong) The 
samples were aliquoted into five 0.5 ml eppendorfs and stored at -80 °C for later E2 
concentration measurement. 
FERTIGENIX E2-EASIA is an enzyme immunoassay performed in 
microtiter plate. A fixed amount of estradiol labeled with horse-raddish peroxidase 
(HRP) competes with unlabelled estradiol present in standards or samples for a 
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limited number of specific E2 antibodies. The (E2-HRP-antibody) and the (E2-
antibody) complexes are simultaneously fixed to the wells of the microtiter plate 
coated with anti-rabbit-gammaglobulins in excess. After incubation and washing, 
revelation solution (chromogen tetramethylbenzydine buffered in H2O2) was added. 
Catalyzed by HRP, the mixture changed colour from colourless to raddish purple. 
Hence, darker in colour indicates lower E2 level in samples. 
During the test, 50 |Lil of standards, controls and samples were dispensed 
into appropriate wells. 50 |Lil of estradiol-HRP conjugate followed by 50 |Lil of E2 
antibody were dispensed into the wells. After 2 hours incubation at room 
temperature, the microtiter plate was washed to stop the competition reaction. 200 |Lll 
revelation solution was added into each well and incubated for 30 minutes. The 
reaction was then stopped with 50 )il H2SO4. The amount of product was determined 
by a microplate reader (ELK SOOjuV, Bio-Tek Instruments) with filter at 450 nm and 
reference filter at 630 nm. The E2 concentration of the samples was determined by 
interpolation from a 4-parameter standard curve which was calculated by the 
computer automatically. 
2.2 Assessment of osteopenia development 
Goats were kept in the Animal House for six months to assess the 
development of osteopenia. X-ray, blood and urine samples were taken monthly for 
measuring the changes of BMD and biochemical markers respectively. On the other 
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However, first of all, the biopsy was under a down graded dehydration with 
increasing concentration of ethanol (75 %, 95 %, and 100 %) (Malluche H.H. et al,, 
1979; Baron R. et al., 1981). The specimen was then immersed into xylene. In order 
to ensure the complete infusion of methylmethacrylate (MMA) into the specimen, a 
mixture of xylene with unpolymerized MMA (UMMA) was used. After immersing 
the specimens in UMMA, they were finally immersed into polymerized MMA 
(PMMA) for embedding (Velde J.te. et al., 1977; Schenk R.K. et al., 1984). Except 
PMMA, other embedding media were exchanged daily for better dehydration or 
infusion. The immersed specimen was put into vacuum desiccator for degassing. It 
could increase the infusion rate of both UMMA and PMMA (Boivian G. et al., 
1984). 
The embedded bone specimen was sectioned by Saw Microtome {Leica 
SP1600, Leica Instruments, Nussloch, Germany) (Figure 2.3) into 500 jum thickness. 
The sections were put onto a high resolution X-ray film (Alfa, Structurix D4 PB 
VAC UP AC, Belgium) and exposed under X-ray at 30 KVp for 40 minutes. 
• Figure 2.3: Saw Microtome 
• Machine for thin sectioning of 
“， MMA embedded iliac crest 
LEICA WOO Jsat' 
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hand, iliac crest biopsies, lumbar vertebrae, humeri and calcaneus were collected 
after six months for BMD measurement and biomechanical tests. 
2.2.1 Photodensitometry 
2.2.1.1 Radiography 
The goat was anesthetized by inhalation of halothane. Lateral X-ray films of 
left proximal tibia and calcaneum were then taken with the Aluminum Step Wedge 
(ASW) as calibrator. The power of the X-ray machine {SFR-510, Shower X-ray Co. 
Ltd., Tokyo, Japan) was set at 70 kV, 40 mA and with exposure time 0.25 second. 
The pixel density of the images of the X-ray films on proximal metaphysis 
of tibia and calcaneum were analyzed using a commercially available imaging 
analysis system {PACE System, diagnostiX 2048) with reference to the ASW density. 
The data were in term of thickness (mm) of the ASW calibrator and presented as 
standardized bone density. 
2.2.1.2 Microradiograpgy 
Iliac crest biopsy was sectioned into thin pieces after bone mineral density 
measurement as described in Part 2.2.2.1 below. 
32 
Methodology 
111 Bone mineral density (BMD) measurement 
A highly precise pQCT {Densiscan 2000, SCANCO’ Zurich’ Switzerland) 
(Figure 2.4) was used to measure the BMD of iliac crest biopsies, lumbar vertebrae 
(L2 and L7)，humeri as well as calcaneus in this study (Dambacher M.A. et al., 1998; 
Qin etal., 1997). 
J E O K 
• ^ ^ ^ ^ ^ ^ ^ f ^ H j l ^ H H ^ I I ^ ^ L Figure 2.4: peripheral 
g Q u a n t i t a t i v e Computed 
，Tomography (pQCT) 
1 …‘涵—-—』Bone mineral density (BMD) 
I 一 ， o f humeri is measuring by 
… ^ ^ ^ ^ ^ ^ pQCT 
2.2.2.1 Iliac crest biopsy 
Transverse biopsies were taken from the iliac crests of the goats to monitor 
the changes of trabecular bone mineral density (BMD) for 6 months after operation. 
The goat was anesthetized in the same way as ovariectomy. It was placed in lateral 
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recumbency on an operation table and the skin covering the iliac crest was shaved, 
cleaned and sterilized. Its body was covered by sterilized drapes exposing only the 
incision site and an open osteotomy was then performed. An approximate 3-cm 
incision was made to expose the tuber coxae. By using an osteotome and a hammer, 
a transverse biopsy，approximately 1cm x 0.8 cm x 0.4 cm，was cut (Figure 2.5). The 
sharp edges were trimmed before the incision was closed. Two biopsies were taken 
from each goat. They were obtained alternately from the left and right sides. The first 
biopsy was taken randomly from one side of the goat just before the ovariectomy or 
sham operation. The second one was harvested from the other side after six months. 
、、 % ‘―‘ ’ 誦 ' W Figure 2.5: Iliac crest biopsy 
(A): Hair surrounding the tuber coxae 
邐 J ^ ^ t f ^ B of the iliac crest was cleared and the 
' ' skin was sterilized. 
『，： \ 1 g J P r ^ ' ^ ^ ^ B ^ (B》: An osteotome and a hammer were 
I、.： 、 u s e d to cut the biopsy. 
L M 聽 : : / K l i ^ - i (C): A transverse biopsy was obtained. 
42 
Methodology 
The biopsies were fixed in 75 % ethanol immediately after surgery. Their 
BMD were then measured by a highly precise peripheral Quantitative Computed 
Tomography (pQCT, Demise an 2000，Scanco, Zurich, Switzerland). 
2.2.2.2 Bone autopsy 
After euthanasia of the goats by overdose intravenous injection of 25% 
pentobarbital (50 mg/kg), their second and the seventh lumbar vertebrae (L2 and L7 
respectively) as well as their humeri and calcaneus of both legs were harvested and 
wrapped by gauze soaked with 0.9 % saline. All the specimens were kept at - 20 °C 
before BMD measurement by pQCT and indentation test. 
All the specimens were fixed in custom-made plastic holders for pQCT 
measurement. The transverse iliac crest biopsy was fixed vertically in the holder and 
the whole sample was scanned. BMD of L2 and L7 were scanned after setting a 
reference line behind the inter-vertebral disc. 7 slides were scanned with 2 mm 
consecutive intervals along the axis. For trabecular BMD of humeral head 
measurement, 15 slides were scanned consecutively along their length after setting a 
reference line to measure the pure volumetric trabecular BMD. However, for the 





Iliac crest biopsy , . . . 
(lateral view) , Lumbar vertebra 
‘ (ventral-dorsal view) 
Lj ,. , Calcaneum Humeral head . . . , . 、 (AP view) (lateral view) 
Figure 2.6: Protocol for BMD measurement of bone specimens by pQCT 
Drawings show the region of the bone specimens for BMD measurement by pQCT. 
Bold line represents the reference line and thin line represents the scanning (slides) 
2.2.3 Biomechanical tests 
Osteoporotic bone shows different mechanical properties when compared 
with normal bone (Burr D.B. et al.’ 1997; Audekercke R.V. et al., 1994; Hernefalk L. 
et al., 1995; McCalden R.W. et al., 1997; Peng Z. et al., 1999). Biomechanical tests, 




2.2.3.1 Screw insertion and pullout test 
Distal femora, tibiae and lumbar vertebrae 4 (L4) were screwed bicortically 
six months after Ovx or Sham operation. Both the femora and tibiae were screwed 
lateral-medially while the lumbar vertebrae were screwed by left peritoneal approach 
as described below. Cancellous bone ~ the distal metaphyses of the femora and 
tibiae as well as L4, were screwed with commercial available cancellous screws. 
Whereas the cortical bone - the diaphyses of the femora and tibiae, were screwed 
with commercial available cortex screws. 
The cancellous screws for the goats in Part I were 4.0 mm, 2.0 mm and 1.75 
mm in thread diameter, core diameter and pitch respectively. However, the 
cancellous screws for the goats in Part II were larger, with 6.5 mm, 3.0 mm and 2.75 
mm respectively of those parameters. This kind of cancellous screw is commonly 
applied for fracture fixation in human adults. The smaller screw is more appropriate 
for the insertion in goats due to their relatively small bone size. On the other hand, in 
both Parts, cortical bone including the diaphyses of femora and tibiae, were screwed 
with the same commercial available cortex screws with parameters of 4.5 mm, 3.0 
mm and 1.75 mm respectively. All the screws were full threaded. The screw head has 
a hexagonal socket and spherical underside. (Stryker (China) Ltd. Hong Kong). The 
diameter of the drill bit for the cancellous and cortical bone in Part I was 2.5 mm and 
3.2 mm respectively. However, the drill bit for both cancellous bone and cortical 
bone in Part II was 3.2 mm in order to fit with its core diameter. 
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Left or right hind limb of the goat was selected randomly for screw 
insertion. L4 was screwed two weeks later in order to reduce the pain and trauma 
caused to the goat. The goats were finally euthanized after a further 4 weeks caring 
(Figure 2.7). 
6 months 2 weeks 4 weeks 
DayO Month 6 / 
(DO) / _ ) / 
< ( 千 ‘ 〉 卜 > 
< Monthly blood and urine collection; 
^ ^ ^ and X-ray film analysis ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ A 
• Ovx / Sham • Screw insertion in Screw insertion in / 
• 1 St iliac crest biopsy femur and tibia lumbar vertebra 4 
• baseline of blood • iliac crest biopsy [ 
and urine collection • /卜 blood and urine • Euthanasia 
collection • Bone autopsies 
collection 
Figure 2.7: Time schedule of the study 
.F igu re shows the schematic schedule of the operations and assessments in the study. 




The goat was fasted and general anesthesia was performed. Two X-ray films 
of the femur, one lateral view and one anterial posterial (AP) view, were taken to 
estimate the sites for the screw insertion. After shaving and skin aseptic preparation, 
a lateral 5 cm longitudinal skin incision was made. Dissecting and retracting the 
fascia lata, lateral vastus muscle and periosteum, lateral surface of the femur was 
exposed. 
By referring to the lateral view X-ray film, a pilot hole was drilled at the 
diaphysis of 35 % of the length of the femur measuring from the apex of the distal 
femur. The drilling was performed by using a compressed gas power drill (Synthes) 
under 600 kPa, perpendicularly to its longitudinal axis. After its depth had been 
measured by a depth gauge, the drill hole was tapped by using a tap with 4.5 mm 
diameter. The cortex screw with appropriate length was then inserted bicortically, left 
behind a distance about 4 mm from the bone surface to the underneath of the screw 
head (Figure 2.8). 
The cancellous screw was inserted into the metaphysis of the distal femur. 
By referring to the X-ray film taken from AP view, the screw was inserted into a 
position where the distance from it to the apex of the distal femur was the same as 
the width of the distal femur. This procedure was used to ensure that the cancellous 
screw was inserted into the cancellous bone. The detail of the screw insertion site 
was shown in (Figure 2.8). 
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、•,:::' Figure 2.8: Positions of screw insertion 
m ；：：：3 H in femur 
-'》i (A): Cortex screw (4.5 mm in thread 
《 d i a m e t e r ) was screwed into the diaphysis at 
a I ^ P 7。:::、A' W B 35 % of the length (a) of the femur from the 
• apex of the distal end. 
fe； - v y ^ ^ i " in (B): Cancellous screw (4.0 mm in thread 
『 ' : I diameter) was screwed into the distal 
‘ J metaphysis at the position with distance 
V ^ from the apex similar to the width of the 
^ E M e ^ r distal end (.). 
2.2.3.1.2 Tibiae 
Screw fixation in tibia was started after the incision of the femur had been 
closed. Totally 2 longitudinal incisions were made during screw fixation in tibia. The 
first incision was about 3 cm and made on the midshaft of tibia. After dissecting and 
retracting the soleus and the peroneus longus, one cortex screw was inserted into the 
diaphysis at the regions of 35 % of length of the tibia measuring from the apex of the 
distal tibia. After the incision was closed, the cancellous screw was inserted into the 
metaphysis of distal tibia of the goat in the position determined in the same way as 
that in the distal femur. The screw insertion procedure was the same as that described 
in Part 2.2.3.1.1. 
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2.2.3.1.3 Lumbar vertebrae 
In order to prevent bleeding from dorsal aorta, left lateral peritoneal 
approach was adopted to expose the lumbar vertebrae. After anesthesia and aseptic 
skin preparation, a 10-cm incision was made. Thoracolumbar fascia and internal 
abdominal oblique were retracted to expose the transverse processes. The lumbar 
vertebral body was exposed after the lumbar muscles were elevated by fingers and 
held by retractor. After drilling, 3.5 mm long cancellous screw was screwed into the 
L4 until 10 mm of screw shaft was left. 
At the end of the study, the goat was euthanized by the injection of overdose 
pentobarbital (50 mg/kg) into its jugular vein. All the femora, tibiae and calcaneus as 
well as the lumbar vertebrae (L2, L4 and L7) were collected by disarticulation. The 
muscles or tendons attaching on the bone were also excised. The samples were then 
wrapped by gauze soaked with 0.9 % saline immediately to prevent dehydration. 
After taking X-ray films for record, each long bone was cut into 2 distal 
blocks by Low Speed Saw {ISOMET，Illinois, USA). 0.9 % saline was added for 
lubrication and cooling during the sawing process. All the distal blocks of femora 
and tibiae as well as L4 were used for biomechanical pullout test. All the specimens 
were preserved at -20 
The bone specimens with screw inserted were embedded in commercial 
available resin {Performance Polymers (UREOL 5202-1), Ciba Specialty Chemicals, 
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Hong Kong) to form a standard block. Before the pullout test, the specimens were 
thawed overnight at room temperature. The screw head was clamped by a custom-
made mechanical jig which was fixed oti a material testing machine with a load cell 
of 10 kN {KM 25，Hounsfield, Redhill,，United Kingdom) (Figure 2.9). In order to 
ensure that the test involves only the simple pullout, the screw was set parallel to the 
loading axis of the jig. Besides, the joints of the jig were not fixed and self-aligning 
was allowed during the test. 
mmm 
Figure 2.9: Screw pultout test 
Photos show the embedding process and the screw pullout test. (A): thawed bone specimen 
wrapped by gauze soaked with 0.9 % saline was fixed into a custom-made jig. (B): the 
specimen was wrapped with aluminum foil. Adhesive stick was used to fill the gap between 
the specimen and the jig to make a circular barrier with standardized diameter, so that resin 
in liquid form cannot flux in. Radius (distance between the screw and the resin〉was thus 
standardized and reduce the error during the pullout test (C): resin was poured into a mould 
with standard size. (D): bone specimen was embedded in the resin block with standard size. 
(E): pullout test was performed by Hounsfield material testing machine after the block had 
been fixed on the custom-made apparatus. 
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The pullout test was set at a low constant testing speed of 10 mm/min. The 
speed selected was based on simulation of physiological conditions that loosening of 
implants from osteoporotic bone occurred unnoticeably. Therefore, no high impact 
force was expected. Besides, no attempt was made to remove any bone marrow 
before testing. The whole process was accessed at room temperature. The ultimate 
strength (N) was recorded for data analysis. 
2.2.3.2 Indentation test 
Cancellous regions of both the humeral head and posterior calcaneum of 
goat were used for the indentation test. In order to expose the cancellous region, the 
humeral head was first cut into a block along the loading axis of the humerus. Then, 
the first 8 mm (measured from the apex) of the humeral head was removed to expose 
the cancellous bone. For the calcaneum, however, the first 5 mm from posterior apex 
was removed. Then, the following 8-mm specimen was harvested for the test. Both 
the cuttings of the calcaneum were perpendicularly to its longitudinal axis so that the 
two faces were parallel. All the preparations were performed by using the Low Speed 
Saw {ISOMET, Illinois, USA) (Figure 2.10A). During the sawing process, 0.9 % 
saline was added for cooling. 
All the specimens had been thawed overnight at room temperature before 
testing. The test was performed using the materials testing machine (KM 25’ 
Hounsfield, Redhill, United Kingdom) (Figure 2.10). The upper loading device (a 
cylindrical stainless steel rod) was connected to a 1000 N load cell, and the samples 
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were tested under a slow loading speed of 2 mm/min to minimize the viscous effect 
and to get a more precise result. The total displacement of the indentation was set at 
3 mm. The diameters of the stainless steel rod for the humeral head and the 
calcaneum were 4 mm and 2.5 mm respectively. The contact point between the rod 
and the specimen was set at the center of the specimen for standardization. All the 
specimens were kept moist with 0.9 % saline during preparation and whole testing 
procedure to minimize dehydration. The test was carried out at room temperature. 
The total indentation work done was calculated by summating the area under the 
loading-displacement curve. 
國 
Figure 2.10: Indentation test 
Photos show the procedure of indentation test on calcaneum. (A): Low Speed Saw 
{ISOMET) was used to remove the posterior apex of the calcaneum. Exposing the 
cancellous bone. The specimen was then cut so that the surfaces at both ends were parallel. 
(B): The specimen was fixed in a holder by 3 screws without screwed into the specimen. The 
central region to be tested was marked by a circular paper. (C): A custom-made stainless 
steel rod with 2.5 mm diameter was connected to the Hounsfiefct materia丨 testing machine 
and used for the indentation test. 
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2.2.4 Biochemical markers measurement 
Biochemical markers of bone remodelling can be divided into two main 
categories: Bone formation and bone resorption. Bone-specific alkaline phosphatase 
(BALP) and osteocalcin (OC) are two of the commonest markers for bone formation 
whereas deoxypyridinoline (Dpd) is one of the markers specific for bone resorption. 
In the present study, serum BALP and OC activity and urinary Dpd concentration 
were measured. 
2.2.4.1 Blood collection 
Blood was collected in the morning to minimize diurnal variation. After the 
goat was anesthetized, 10 ml of blood was drawn from its great saphenous vein in the 
forelimb by using a 10-ml syringe. The blood was then transferred to a serum tube 
for later processing. The baseline was drawn just before ovariectomy or sham 
operation and the follow-up blood collection was performed monthly. Serum was 
obtained after centrifuging the blood sample at 3000 rpm and 4 for 10 minutes 
(JEC CENTERA-GPS, South East Chemicals and Instruments Ltd. Hong Kong). The 
serum was aliquoted into five 0.5 ml eppendorfs and stored at -80 °C for later 
biochemical markers measurement. 
2.2.4.2 Urine collection 
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Monthly urine collection by intubation via urethra of the goat was 
performed in the morning to minimize diurnal effect. The sample collected just 
before ovariectomy or sham operation served as baseline. 10 ml of urine was 
collected each time and was aliquoted into five 0.5 ml eppendorfs afterwards. All the 
samples were stored at -80 °C before testing. 
2.2.4.3 Bone-specific Alkaline Phosphatase (BALP) 
BALP is a tetrameric glycoprotein localizing in the plasma membrane of 
osteoblasts. The enzyme is thought to be involved in bone formation and skeletal 
mineralization in vivo (Garnero P. et al., 1993; Fishman W.H., 1990; Rodan G.A. et 
al., 1982; McComb R.B. et al., 1979). 
Measurement of BALP activity was performed according to the ABA-100® 
procedure of the ABBOTT VP System {Abbott Laboratories, Texas, USA) via Wheat 
Germ Lectin (WGL) precipitation (Liu P.P. et al., 1996; Leung K.S. et al., 1993; 
Rosalki S.B. et al., 1986). Both non bone-specific and total ALP activities were 
measured during the measurement. 
Stored serum samples were first thawed at room temperature (23°C). To 
measure the non bone-specific ALP activity, 0.5 % reagent for precipitation of BALP 
was prepared by dissolving WGL (from Triticum vulgaris) {Sigma) into 4 % Triton 
X-100 solution. 50 |il serum sample was then added to 50 |Lil reagent and incubated at 
37 °C with shaking. After the incubation, the mixture was centrifuged at 12,000 ipm 
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for 10 minutes and the supernatant was then collected for measurement of non bone-
specific ALP activity. Total ALP activity was measured in the same way as that of 
non bone-specific ALP activity except WGL-free Triton X-100 solution was used. 
BALP activity was calculated by subtracting the non bone-specific ALP 
activity from the total ALP activity. All the data were expressed in lU / L. 
2.2.4.4 Osteocalcin (OC) 
Osteocalcin, also called Bone gla protein (BGP), is a vitamin K dependent 
protein produced by the osteoblasts. It accounts for 10 to 20 % of the noncollagenous 
protein in bone. Although the in vivo function of OC is unknown, it plays a role in 
bone formation (Akesson K., 1995; Price P.A. et al., 1981) and bone mineralization 
(Lian J.B. et al., 1982). In this study, a competitive immunoassay ELISA kit^ 
(NovoCalcin - Metra Bio systems®, California, USA) was used to measure the BGP 
level in the serum of goats. The assay uses osteocalcin coated strips, a mouse anti-
osteocalcin antibody, an anti-mouse IgG-alkaline phosphatase conjugate and a p-
Nitrophenyl phosphate substrate to quantify osteocalcin in serum. 
2.2.4.4.1 Sample and reagent preparation 
Stored serum samples were thawed at room temperature before the 
measurement. Meanwhile, the lOX Wash Buffer (a nonionic detergent in a buffered 
solution containing 0.05 % sodium azide as preservative) was diluted to form IX 
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Wash Buffer. The samples were then diluted 10 times while the Standards and 
Controls were reconstituted with 0.5 ml of the IX Wash Buffer. 
25 [i\ of serum samples, Standards and Controls were loaded into the 
corresponding wells. 125 |Lil of Anti-Osteocalcin were then delivered into each of the 
wells using an 8-channel pipette followed by a 2-hour incubation at room 
temperature. All the wells were emptied by inverting the strips after the incubation 
and were washed with 300 |Lil IX Wash Buffer for 3 times. The wells were blotted to 
dry vigorously on paper towels after the last wash to ensure the complete removal of 
unbound anti-osteocalcin. 150 |il Enzyme Conjugate was then delivered into the 
wells by an 8-channel pipette followed by 1-hour incubation at room temperature. 
Meanwhile, Working Substrate Solution was prepared by putting Substrate 
Tablet(s) (20 mg of p-Nitrophenyl phosphate) into each bottle of Substrate Buffer (a 
diethanolamine and magnesium chloride solution containing 0.05 %sodium azide as 
preservative). More than 30 minutes was allowed to dissolve the tablet(s) completely 
and the bottles were then shaken vigorously to ensure complete mixing. Each well 
was washed with 300 |Lll of IX Wash Buffer for 3 after the incubation. After blotting, 
150 \i\ Working Substrate Solution was added to each well. The plate was incubated 
for 35 to 40 minutes and measured colourimetrically (optical density measurement). 
2.2.4.4.2 Measurement 
Optical Density (OD) at 405 nm was measured by a microplate reader (ELX 
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SOOjiV, Bio-Tek® Instruments). The first reading was performed right after the 35-
minute incubation without the addition of Stopping Solution. To ensure there was an 
optimum reaction, the readings from Standard A well were monitored. 50 
Stopping Solution was added into all the wells once the readings of Standard A 
reached 1.5. Final reading was taken within 15 minutes after the Stopping Solution 
was added. 
A 4-parameter standard curve was calculated automatically by the computer 
and the concentration of samples and Controls were determined from the curve. The 
data obtained from this assay were expressed in ng/ml. Samples with OC 
concentration greater than 32 ng/ml were further diluted in IX Wash Buffer and 
retested. 
2.2.4.5 Deoxypyridinoline (Dpd) and urine creatinine 
Deoxypyridinoline is one of the crosslinks of mature type I collagen in bone 
(Seyedin S.M. et al, 1990; Delmas P.D., 1995). This crosslink is formed by the 
enzymatic action of lysyl oxidase on the amino acid lysine (Seibel M.J. et al., 1992). 
Dpd is released into the circulation during the bone resorption process (Seibel M.J. et 
al, 1992; Delmas RD. et al., 1991; Eastell R. et al., 1997). An ELISA kit {Pyrilinks-
D -- Metra Biosystems®, California, USA) for measuring the level of Dpd in urine 
was used in the present study. 
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2.2.4.5.1 Sample and reagent preparation 
The stored urine samples were first thawed at room temperature. After the 
samples, Standards and Controls were diluted 10 folds with Assay Buffer, the 
Stripwell Frame and the Anti-Dpd Coated Strips were removed from the pouch. 
Enzyme Conjugate was then reconstituted with 7 ml Assay Buffer (a nonionic 
detergent in a buffered solution containing 0.05 % sodium azide as preservative) and 
stored at 4 °C. 
50 of diluted samples, Standards and Controls were loaded into the 
corresponding wells. 100 jil of reconstituted Enzyme Conjugate, which was used for 
the competition of the Anti-Dpd with the Dpd in the samples was added. The mixture 
was then incubated at 4 °C in the dark for 2 hours. Meanwhile, Working Substrate 
Solution (20 mg of p-Nitrophenyl phosphate dissolved in a diethanolamine and 
magnesium chloride solution containing 0.05 % sodium azide as preservative) and 
IX Wash Buffer (a nonionic detergent in a buffered solution containing 0.05 % 
sodium azide as preservative) were prepared. 
After incubation, the wells were emptied by inverting the strips and at least 
250 jil of IX Wash Buffer was added 3 times to remove the unbound enzyme 
conjugate. The strips were blotted to dry vigorously on paper towels after the final 
wash. 150 |il of Working Substrate Solution was then added into each well followed 




Optical Density (OD) at 405 nm was measured by a microplate reader {ELX 
SOOflV, Bio-Tek® Instruments). 100 |Lll of Stop Solution was not added until the OD 
reading from Standard A well reached between 1.2 and 1.5. All the readings were 
made within 15 minutes after the addition of the Stop Solution. 
A 4-parameter standard curve calculated by the computer was used for 
accurate results. Concentration of samples and Controls were determined from the 
standard curve automatically and the data obtained from this assay were expressed in 
nmol/1. Samples with Dpd concentration greater than 300 nmol/1 were further diluted 
by IX Assay Buffer and retested. 
2.2.4.5.3 Standardization of urine concentration 
To correct for the variations due to the urine concentration, urine creatinine 
level was measured. Same urine samples as those for Dpd test were used for 
measurement. Creatinine working reagent was firstly prepared by mixing 10 ml of 
0.1 M NaOH with 10 ml 0.03 M picric acid. The samples were then diluted 20 times 
with distilled water. 100 jil of distilled water (as blank), standards as well as the 
d i l u t e d s a m p l e s w e r e p i p e t t e d i n t o a 9 6 - w e l l p l a t e f o l l o w e d b y l o a d i n g o f 2 0 0 |Lil 
working reagent. A thirty-minute incubation at room temperature was allowed and 
the concentration of the samples was measured by a microplate reader {ELK 800/iV, 
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Bio-Tek® Instruments) at 510 nin. The result of creatinine level was expressed in 
mM. 
The results of the Dpd assay were normalized by dividing the Dpd value by 
the creatinine concentration (Bikle D.D., 1997). In other words, the Dpd level was 
expressed as nM/mM. 
2.3 Statistical analysis 
Median and median percentage change from baseline was calculated for 
statistical analysis. Non-parametric tests were then applied in this study. Wilcoxon 
Test was used to compare the data between the baseline and that after 6 months. 
However, Mann-Whitney U Test was used for comparing the data of Ovx group with 
that of Sham group. All the data were analyzed by the SPSS (Ver 9.0) software. 
Some of the results were presented using box-plot: The middle bold bar in the box is 
representing the median. The upper edge of the box is showing the 75出 percentile 
when the lower edge of the box is representing the 25"�percentile of the data. The 
"whiskers" at the top and at the bottom of the box are representing the and 
percentile, respectively of the data. 
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Results 
Chapter 3: Results 
3.1 Animal distribution 
In the present study, twenty-nine female Chinese mountain goats were used. 
They were separated into two main parts. All the goats in both parts were operated 
with standardized ovariectomy (Ovx) or sham operation (Sham) procedures. 
In Part I, sixteen skeletal mature goats were used. Eleven of them were 
assigned into the Ovx group while five were selected into the Sham group randomly 
before the operation (Figure 3.1). X-ray was taken to monitor the changes in bone 
density of the goats after operation. On the other hand, cancellous screws with 4.0 
mm diameter were inserted into different cancellous regions of the goats in this part 
(Table 3.1). Four out of eleven skeletally mature goats in the Ovx group died. One 
died before ovariectomy, two died within one month while one died one month after 
the operation. In the Sham group, two goats passed away. One died before the 
operation and one died within one month after the operation (Figure 3.1). All the 
remaining goats were kept in a healthy condition. 
In Part II，thirteen goats which were skeletally immature were used to see if 
they can also be the animal model for osteopenia. Nine of them were subjected to 
ovariectomy while four of them were allocated for sham operation (Figure 3.1) 
randomly. Moreover, 6.5 mm diameter cancellous screws were inserted into the 
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cancellous region of the goats in this part. Some parameters including the 
photodensitometry and the bone mineral density (BMD) measurement by peripheral 
quantitative computed tomography (pQCT) of the lumbar vertebra 2 (L2) could not 
be provided due to unavailability of the machine (Table 3.1). In this part of the study, 
one goat in the Ovx group died before the operation and one died after 2 months of 
the operation (Figure 3.1). 
The baseline values of all parameters between the Ovx group and the Sham 
group were without significant difference under the non-parametric Mann-Whitney 
U Test. The results of this study were summarized in Table 3.2. 
Total Number of Goats 
n 二 29 
Part I: Skeletal Mature Goats Part II: Skeletal Immature Goats 
n = 16 n = 13 
Ovx Sham Ovx Sham 
n = 11 (4) n = 5(2) n = 9 (2) n = 4 
Figure 3.1: The schematic summary shows the distr ibution of the goats in the study 
"n" represents the number of goats in each category. Totally 29 goats were obtained. 16 
skeletal mature goats were used and grouped in Part I. In Part 11’ 13 of them were skeletal 
immature. There were two groups in each Part: ovariectomy (Ovx) or sham operation 
(Sham). The number in the blanket is the number of goats died during the study. 
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Part I Part II 
Goat skeletal maturity mature immatum 
Diet for Ovx low calcium normal 
Confirmation of Histology of ovary ^ ^ 
successful Ovx ^^ • • 
Photodensitometry Proximal Tibia ^ ^ 
Calcaneum ^ X 
Iliac crest biopsy ^ X 
Densitometry Iliac crest biopsy ^ 
(BMD measurement Lumbar ve r t eb ra (L2) X 
by pQCT) 
Lumbar vertebra (L7) ^ ^ 
Calcaneum ^ ^ 
Humeral head ^ ^ 
Biomechanical test Cancellous screw 0 4.5 mm 0 6.5 mm 
Pullout test ^^ 
Indentation ^ ^ 
Biochemical BALP ^ ^ 
markers 〇〇 • • 
Dpd 
Table 3.1: Table shows the differences between the two parts in the study 
The parameters those were available in the study are labeled with The data that could not 
be obtained is labeled with X . 0 represents the core diameter of the screw. 
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Skeletal Skeletal ~ 
Mature Immature 
Parameters Ovx Sham Ovx Sham 
Serum E2 ~ f T ~ 
Photodensitometry Proximal tibia i ^^ T NA NA 
(X-ray) Calcaneum T NA NA 
Densitometry Iliac crest biopsy i ^^ T T 个 
(BMD measurement Lumbar vertebra 2 Ovx < Sham ^ NA 
by pQCT) Lumbar vertebra 7 Ovx < Sham ^ NS 
Calcaneum Ovx < Sham ^ NS 
Humeral head Ovx < Sham ^ NS 
Screw pullout test Lumbar vertebra 4 Ovx < Sham ^ NS 
Femur (distal metaphysis) Ovx < Sham ^ NS 
Femur (diaphysis) NS NS 
Tibia (distal metaphysis) Ovx < Sham ^ NS 
Tibia (diaphysis) NS NS 
Indentation test Calcaneum Ovx < Sham ^ NS 
Humeral head Ovx < Sham ^ NS 
Biochemical BALP P f T T ^ 
markers 〇C T & t T 八 
Dpd i i i ^ 
Table 3.2: Summary of the results 
The table summarizes the results of the study. 
"T" represents an increase while "i" represents a decrease observation; 
"<"represents lower than; 
"NA" means that data is not available; 
"NS" means no significant difference between the Ovx and the Sham group; 
a : significant difference between the Ovx and the Sham group at the six months post-
operation; 
b: significant difference between the sixth month and baseline in the same group 
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3.2 Confirmation of successful ovariectomy 
Ovariectomy was successful as confirmed by histological analysis of the 
excised organ. Although the appearance of the ovary, the pattern of the ovarian cycle 
and the state in the cycle at which the ovary is examined varies considerably 
depending on the species, the ovary of all mammals have a similar structure. Figure 
3.2 shows the most obvious and distinguishable structures of goat ovary - the 
presence of follicles although they are difficult to be observed in human ovary under 




. — F 
CL C 
Figure 3.2: Excised organ f rom goat during ovariectomy showing the characteristics 
of oyary (H&E x11) 
The excised organ during ovariectomy showed the characteristics of an ovary. It is a 
flattened, ova丨 organ encapsulated in a tunica albuginea T.丨门 the peripheral zone，numerous 
fofficies F containing female gametes at various stages of development. CL represents the 
corpus luteum remained after ovulation. The central zone of the stroma is the medulla M, is 
highly vascular and contains few follicles. L is the broad ligament through which blood 
vessels, nerves and lymphatics enter the ovary. 
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3.3 Assessments in skeletal mature goats (Part I) 
The development of osteopenia in goats was assessed by photodensitometry, 
pQCT, biomechanical tests and biochemical markers. Photodensitometry measured 
the bone mineral density from the X-ray films of the bone. pQCT measured the 
change of BMD of the goat. Biomechanical tests showed the difference in bone 
quality between the Ovx group and Sham group while of the changes of biochemical 
markers gave information on the process of bone remodelling in goats. 
3.3.1 Estradiol (E2) assessment 
Serum E2 was used to assess the success of ovariectomy. Median percentage 
change from baseline of the serum E2 concentration was measured monthly and the 
result is shown in Figure 3.3. 
The median percentage change of serum E2 concentration of the Ovx group 
decreased sharply (42.3 %, p = 0.017) within the first month after the operation. It 
then remained at low level and a mild continuous decrease afterwards (Figure 3.3). 
There was a significant 52.4 % decrease 6 months after the operation (p = 0.017) 
(Table 3.3). However, the median percentage change of serum E2 of the Sham group 
increased after the operation until the second month and then dropped. It decreased 
24.1 % finally (Figure 3.3). No significant change was found when the data in the 
sixth month was compared with that in the baseline (p = 0.109) (Table 3.3). On the 
other hand, the median percentage change of serum E2 concentration between the 
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two groups showed a significant difference starting in the first month after the 
operation (Table 3.3). 
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Figure 3.3: Median percentage changes f rom baseline of serum estradiol (E2) 
concentrat ion of the skeletal mature goats after the operation 
A sudden decrease in E2 concentration was observed in the ovariectomized goat (Ovx) after 
ovariectomy. No significant change was found in the sham operated goat (Sham). The p-
vatues and the sample sizes of each group in each month are showed in Table 3,3 below. 
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Group Month(s) post-op 0 1 2 3 4 5 6 
Median % change 。 ^ ^ 
0.00 -42.30^ -42.38^ -46.78^ -47.28^ -49.56^ -52.39曰& 
Ovx from baseline 
nZ To 8 7 7 7 7 7 
Median % change 
^^ 0.00 14.40 17.18 6.05 -15.73 -21.98 -24.06 
Sham from baseline 
r^ 4 3 3 3 3 3 3 
Table 3.3: The monthly median percentage changes from baseline of serum estradiol 
(E2) concentration of the skeletal mature goats within 6 months after operation 
"n" represents the sample size of the goats in respective month of the group 
"a" shows the significant difference between the two groups in the same month; p =0.017 
"b" shows the significant difference between the sixth month and the baseline within the 
same group; p = 0.018 
3.3.2 Photodensitometry 
Photodensitometric analysis was performed only for the skeletal mature 
goats. The X-ray machine was unavailable to record the baseline X-ray images of the 
skeletal immature goat. Percentage change from baseline could not be calculated and 
thus no analysis could be done for the skeletal immature goat. Monthly radiography 
of both the Ovx group and the Sham group of the skeletal mature goat was taken 
with an aluminum step wedge (ASW) calibrator. The pixel density of the images on 
the X-ray films of the left proximal metaphysis of tibia and left calcaneum was 
standardized with that of the ASW calibrator. The values were in term of thickness 
(mm) of the ASW calibrator and presented as "standardized bone density". The 
baseline radiography was taken before the ovariectomy or the sham operation. The 
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median percentage change from baseline was analyzed. 
3.3.2.1 Proximal metaphysis of tibia 
From photodensitometric analysis, the median percentage change of the 
standardized bone density of the tibial proximal metaphysis of the Ovx group 
decreased gradually after the operation. A contrary observation was found in the 
Sham group, which increased gradually after the operation (Figure 3.4). A significant 
decrease of 21.6 % of standardized bone density of proximal tibia was found in Ovx 
group (p = 0.028) whereas non-significant increase of 30.1% was observed in Sham 
group (p = 0.285) six months after the operation. As a result, a significant difference 
was found between the two groups at the end of the study (p = 0.033) (Table 3.4), 
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Figure 3.4: Median percentage changes f rom baseline of the standardized bone 
density of proximal metaphysis of t ibia of the skeletal mature goats 
The standardized bone density of the proximal metaphysis of tibia in the Ovx group 
decreased gradually but that of the Sham group increased non-significantly. The p-values 
and the sample sizes of groups in each month are showed in Table 3.4 below. 
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Group Month(s) post-op 0 1 2 3 4 5 6 
Median % change “ 
0.00 -6.35 3.49 -7.21 -13.36 -15.26 -21.63油 
Ovx from baseline 
n= 10 8 7 7 7 7 7 
Median % change 
0.00 1.78 10.30 15.58 9.17 21.00 30.28 
Sham from baseline 
n= 4 3 3 3 3 3 3 
Table 3.4: The monthly median percentage changes from baseline of the standardized 
bone density of proximal metaphysis of tibia of the skeletal mature goats after the 
operation 
"n" represents the sample size of the goats in respective month of the group 
"a" shows the significant difference between the two groups in the same month; 
p = 0.033 
"b" shows the significant difference between the sixth month and the baseline within the 
same group; p = 0.028 
3.3.2.2 Calcaneum 
The median percentage change of the standardized bone density of the 
calcaneum of the goats in the Ovx group decreased by 18.1 % significantly after the 
operation (p = 0.043). In the Sham group, however, it increased after the operation. A 
35.5 % increase in standardized bone density was recorded at the end of the study (p 
=0.285) (Figure 3.5). Significant difference between the two groups was observed at 
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Figure 3.5: Median percentage changes from baseline of the standardized bone 
density of calcaneum of the skeletal mature goats after the operation 
A gradual decrease of standardized bone density of the calcaneum was observed in the Ovx 
group but an increase was found in the Sham group. The p-values and the sample sizes of 
groups in each month are showed in Table 3.5 below. 
Group Month(s) post-op 0 1 2 3 4 5 6 
Median % change 0.00 -5.10 -3.57 -19.09^ -15.33 -15.79 -18.08^^ 
from baseline 
n= 10 8 7 7 7 7 1 
〜 m Median % change 0.00 11.83 13.17 41.40 18.01 15.86 35.48 
咖 m from baseline 
n= 4 3 3 3 3 3 3 
Table 3.5: The monthly median percentage of the standardized bone density of 
calcaneum of the skeletal mature goats within 6 months after the operation 
"/?" represents the sample size of the goats in respective month of the group 
"a" shows the significant difference between the two groups in the sixth month post-
operation; p = 0.033 
shows the significant difference between the sixth month and the baseline within the same 
group; p 二 0.043 
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3.3.2.3 Iliac crest biopsy 
No suitable aluminum step wedge calibrator could be used for analysis in 
this part due to the thin thickness (500 )am) of the sectioned biopsy. Therefore, no 
standardized bone density was provided. X-ray images were shown to describe the 
architecture of the biopsies between the Ovx group and the Sham group. Figure 3.6 
shows the difference of the architecture of iliac crest biopsies of the Ovx group 
before and after 6 months. Number of trabeculae in iliac crest of the goat was 
obviously reduced 6 months after the ovariectomy. However, the biopsies harvested 
from the goat in the Sham group neither showed the reduction in trabeculae number 
nor volume. 
3.3.3 Bone mineral density (BMD) measurement — by peripheral Quantitative 
Computed Tomography (pQCT) 
Bone mineral density by pQCT of iliac crest biopsy provided both intra-
group (between baseline and the sixth month post-operation within the same group) 
as well as inter-group comparison (Ovx group vs Sham group). However, lumbar 
vertebra, calcaneum and humeral head autopsy could provide only the inter-group 
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F igu re 3.6: Images of h igh reso lu t i on X-ray f i lm of the i l iac c res t b i o p s i e s 
The upper two iliac crest biopsies are from one ovariectomized skeletal mature goat 
fed with low calcium diet. The lower two are from a sham operated goat. The 
biopsies on the 丨eft side are the baseline that harvested before the operation and the 
ones on the right side are obtained after the goat was euthanized. The number of 
t rabeculae in the iliac crest biopsy of the ovariectomized 6 months after operation 
(upper-right) reduced obviously. 
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3.3.3.1 Iliac crest biopsy 
Two iliac crest biopsies were harvested from each goat. The first one 
obtained before ovariectomy or sham operation served as baseline while the second 
one obtained after the euthanasia of the goat. 
Eleven and 4 iliac crest biopsies were harvested from the Ovx group and the 
Sham group respectively before the operation as baseline. However, only 7 
specimens for the Ovx group and 3 specimens for the Sham group were collected at 
the end of the study due to the death of some goats. The median percentage change 
of BMD of iliac crest of the goats in the Ovx group dropped by 31.7 % significantly 
after 6 months (p = 0.028), whereas that in the Sham group increased by 15.4 % and 
had no statistical significance (p = 0.109) (Figure. 3.7). When the median percentage 
change of BMD of the iliac crest biopsy at the sixth month of the Ovx group was 
compared with that of Sham group, a significant difference (p = 0.017) was found 
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Figure 3.7: Median percentage changes from baseline of the BMD of iliac crest biopsy 
of the skeletal mature goats after the operation 
The BMD of the Ovx group decreased significantly but that of the Sham group increased 
after the operation. The p-values and the sample sizes of the groups in each month are 
showed in Table 3.6 below. 
Group Month(s) post-operation 0 6 
Ovx Median % change from baseline 0.00 -31.66^^ 
A7= 10 7 
Sham Median % change f rom baseline 0.00 15.37 
n= 4 3 
Table 3.6: Median percentage changes of the BMD of iliac crest biopsies in the skeletal 
mature goats 6 months after the operation 
"n" represents the sample size of the goats in respective groups 
"a" shows the significant difference between the two groups in the sixth month after 
operation; p = 0.017 
"b" shows the significant difference between the sixth month and the baseline within the 
same group; p == 0.028 
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3.3.3.2 Lumbar vertebrae autopsy 
Lumbar vertebra 2 (L2) and 7 (L7) of the goats were harvested right after 
they had been euthanized. Seven L2 and L7 were collected from the Ovx group 
whereas three of each were obtained from the Sham group. The median BMD of the 
L2 and L7 of the Ovx group was 0.2 g/cnr] (-32.78 %) and 0.18 g/cm^ (-28.13 %) 
respectively lower than that in the Sham group (Figure 3.8 and Figure 3.9). 
Significant differences were also found in both L2 and L7 between the two groups (p 
=0.017 and 0.033 respectively) (Table 3.7). 
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Figure 3.8: Median of BMD (g/cm^) in L2 of the skeletal mature goats after operation 
The BMD of the ovariectomized group (Ovx) was significantly lower than that of the sham 
operated goats (Sham) at the end of the study. The sample sizes and p-value are shown in 
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Figure 3.9: Median of BMD (g/cm^) in L7 of the skeletal mature goats after operation 
The BMD of the ovariectomized group (Ovx) was significantly lower than that of the sham 
operated group (Sham) at the end of the study. Sample sizes and p-value are referred to 
Table 3.7. 
Region ^ ^ Dif l 
p-value 
Ovx (n = 7) Sham (n = 3) (Ovx-Sham) 
L2 0.41 0.61 -0.20 (-32.78%) 0.017^ 
L7 0.46 0.64 -0.18 (-28.13%) 0.033^ 
Table 3.7: Median BMD (g/cm^) of the lumbar vertebrae 2 and 7 (L2 and L7) of the 
skeletal mature goats 6 months after the operation 
"n" represents the sample size of the goats in the respective group 
"a" represents significant difference between the two groups 
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3.3.3.3 Calcaneus and humeral heads autopsy 
The mean BMD of each pair of calcaneus and humeral heads from the same 
goat was calculated before statistical analysis. By pQCT measurement, the median 
BMD of both calcaneus and humeral heads of the Ovx group were 0.22 g/cm (-
31.43 %) and 0.11 g/cm" (-26.19 %) lower, respectively, than that of the Sham group 
(Figure 3.10 and Figure 3.11). Moreover, the differences were statistical significant 
in both cases (p = 0.017 for both) (Table 3.8). 
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Figure 3.10: Median of BMD (g/cm^) in calcaneum of the skeletal mature goats after 
operation 
The BMD of the ovariectomized group (Ovx) was significantly lower than that of the sham 
operated goats (Sham) at the end of the study. The sample sizes and p-value are shown in 
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Figure 3.11: Median of BMD (g/cm^) in humeral head of the skeletal mature goats after 
operation 
The BMD of the ovariectomized group (Ovx) was lower than that of the sham operated goats 
(Sham) significantly at the end of the study. The p-value and sample sizes are shown in 
Table 3.8 below. 
Group Diff. 
Region … � � p-value 
Oyx(n = 7) Sham(n = 3) (Ovx-Sham) 
Calcaneum 0.48 0.70 -0.22 (-31.43%) 0.017^ 
Humeral head 0.31 0.42 -0.11 (-26.19%) O.Oir 
Table 3.8: Median BMD (g/cm^) of the calcaneum and humeral head of skeletal mature 
goats after 6 months of the operation 
"n" represents the sample size of the goats in different groups 
"a" represents significant difference between the two groups 
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3.3.4 Biomechanica l tests 
For the biomechanical tests, comparison was made only between the Ovx 
group and the Sham group. Intra-group comparisons at different time points were not 
possible in the present study since autopsies were used. The screws in both femur 
and tibia had been screwed for six weeks before the euthanasia of the goat whereas 
those in L4 had been screwed for four weeks. 
3.3.4.1 Screw pullout test 
Screw pullout strength at the cancellous and cortical bone was measured. 
The fourth lumbar vertebra (L4), distal metaphysis of femur and tibia were used for 
measurement of strength at the cancellous region while the femoral and tibial 
diaphyses were used for the measurement of screw pullout strength at the cortical 
region. Ultimate screw pullout strength was recorded from the loading-displacement 
curve. 
When the ultimate screw pullout strength of the Ovx group was compared 
with that of the Sham group, it was found that, in both cortical or cancellous regions, 
the strength was lower in the Ovx group than that in the Sham group (Figure 3.12 to 
Figure 3.16). However, significant differences were only found in the cancellous 
regions of the bone (p = 0.003 for L4, distal metaphysis of femur and tibia), but not 
in the cortical regions (p = 0.067 and 0.383 for diaphysis of femur and tibia 
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Figure 3.12: Median screw pullout strength (N) from the lumbar vertebra 4 (L4) of the 
skeletal mature goats 
The screw pullout strength of the ovariectomized group (Ovx) was lower than that of the 
sham operated goats (Sham) significantly. Table 3.9 shows the sample sizes and p-value. 
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Figure 3.13: Median screw pullout strength (N) from the diatal metaphysis of femur of 
the skeletal mature goats 
A significant lower screw pullout strength wass observed in the ovariectomized group (Ovx). 











Figure 3.14: Median screw pullout strength (N) from the diaphysis of femur of the 
skeletal mature goats 
The screw pullout strength was lower in the ovariectomized group (Ovx) than that in the 
sham operated goats (Sham). There was no statistical difference. Table 3.9 shows the 
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Figure 3.15: Median screw pullout strength (N) from the distal metaphysis of tibia of 
the skeletal mature goats 
A significant lower screw pullout strength was found in the ovariectomized group (Ovx). 
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Figure 3.16: Median screw pullout strength (N) from the diaphysis of tibia of the 
skeletal mature goats 
Lower but not significant screw pullout strength was found in the ovariectomized group 
(Ovx). Table 3.9 shows the p-value and the sample sizes. 
Group Diff 
Regions _ � ，六 � . � p-value 
^ Ovx (n = 7) Sham (n 二 3) (Ovx-Sham) “ 
Lumbar Vertebra (L4) 1416 1888 -472 (-25.0%) 0.003^ 
Femur Distal metaphysis 1500 2930 -1430 (-48.8%) 0.003^ 
Diaphysis 1808 2030 -222 (-10.9%) 0.067 
Tibia Distal metaphysis 1856 3128 -1272 (-40.7%) 0.003^ 
Diaphysis 2448 2752 -304 (-11.0%) 0.383 
Table 3.9: Median screw pullout strength (N) at different regions of the skeletal mature 
goats 
"n" represents the sample size of the goats in respective group 
"a" represents significant difference between the two groups 
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3.3.4.2 Indentation test 
Calcaneus and humeral heads of the goats were used for the indentation test. 
The total work done required for 3 mm displacement of the cancellous bone of the 
specimens was calculated. 
Total work done required during the indentation test of the calcaneus in the 
Ovx group was 0.27 J lower than that required in the Sham group (Figure 3.17). 
Similar observation was found in the indentation test of humeral heads of the goats. 
0.71 J more work done was needed for the Sham group. (Figure 3.18). The difference 
of work done between the two groups were statistical significant (p = 0.017 for both 
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Figure 3.17: Median indentation work done (J) from the calcaneum of the skeletal 
mature goats 
A significant lower indentation work done was found in the ovariectomized goats (Ovx) when 
compared with that of the sham operated goats (Sham). The p-value and sample sizes are 
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Figure 3.18: Median indentation work done (J) from the humeral head of the skeletal 
mature goats 
Energy required for the indentation in humeral head in the ovariectomized goats (Ovx) was 
lower than that in the sham operated goats (Sham). The decrease was significant and the p-
value and sample sizes are shown in Table 3.10. 
Group Diff 
Regions “ p-value 
Ovx (n = 7) Sham (n = 3) (Ovx-Sham) 
Calcaneum 0.21 0.48 -0.27 (-56.3%) 0.017^ 
Humeral head 0.46 1.17 -0.71 (-60.7%) 0.017^ 
Table 3.10: Median indentation work done (J) at different regions of the skeletal 
mature goats 
"n" represents the sample size of the goats in the respective group 
"a" represents significant difference between the two groups 
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3.3.5 Biochemical markers 
The changes of serum and urinary biochemical markers were presented as 
normalized percentage changes in order to show their differences during the 6 
months of osteoporosis development clearly. Both the blood and urine samples were 
collected from 11 goats of the Ovx group and 5 goats of the Sham group. However, 
owing to the death of some goats, the sample sizes of the Ovx group and Sham group 
reduced to 7 and 3 respectively at the end of the study. Dur to the small sample size, 
median of the data rather than their mean were calculated. 
3.3.5.1 Bone formation markers 
Two biochemical markers, serum bone-specific alkaline phosphatase and 
serum osteocalcin, were used to assess the bone formation after ovariectomy or sham 
operations of the goats. Serum was collected monthly after the operation and samples 
collected just before the operation served as baseline. 
3.3.5.1.1 Bone-specific alkaline phosphatase (BALP) 
Only the Ovx group showed a significant increase in the median percentage 
change of BALP activity 6 months after the operation (p = 0.018 and 0.285 in Ovx 
group and Sham group respectively) (Figure 3.19). The median percentage change of 
the Ovx group reached 256.4 % six months after operation. However, there was only 
8 6 
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149.9 % increase in median percentage change of BALP in the Sham group after the 
operation (Table 3.11). Although there was an approximately 100 % difference 
between the two groups at the sixth month, there was no significant difference 
statistically (p = 0.267). 
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Figure 3.19: Median percentage changes f rom baseline of serum bone-specific 
alkaline phosphatase (BALP) of the skeletal mature goats after the operation 
An increase of BALP activity was observed in the ovariectomized goat (Ovx) and the sham 
operated goat (Sham) after the operation. Significant change was found in the Ovx group 
only. The p-value and the sample sizes of each group in each month are showed in Table 
3 , " below. 
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Group Month(s) post-op 0 1 2 3 4 5 6 
Ovx Median % change 〇 QQ 6.04 92.52 208.94 163.49 270.79 256.54^ 
from baseline 
n= 10 8 7 7 7 7 7 
Median % change 〇〇〇 60.49 246.57 166.26 85.23 159.42 149.93 
bnam from baseline 
n = 4 3 3 3 3 3 3 
Table 3.11: The monthly median percentage changes from baseline of bone-specific 
alkaline phosphatase (BALP) activity of the skeletal mature goats within 6 months 
after operation 
. " n " represents the sample size of the goats in respective month of the group 
"b" shows the significant difference between the sixth month and the baseline within the 
same group; p 二 0.018 
3.3.5.1.2 Osteocalcin (OC) 
The median percentage change of serum OC level of both the Ovx group 
and Sham group increased 6 months after the operation (433.0 % and 103.6 % 
respectively) (Figure 3.20). Nevertheless, only the Ovx group showed a significant 
increase after 6 months (p = 0.018). On the other hand, although the median 
percentage change of OC level of the Ovx group was 4 times higher than that of the 
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Figure 3.20: Median percentage changes from baseline of serum osteocalcin (OC) 
level of the skeletal mature goats after the operation 
An Increase of OC level was observed in the ovariectomized goat (Ovx) and the sham 
operated goat (Sham) after the operation. Significant change was found in the Ovx group 
only. The p-value and the sample sizes of each group in each month are showed in Table 
3.12 below. 
Group Month(s) post-op 0 1 2 3 4 5 6 
Median % ehange • qq -14,69 142.24 145.01 233.94 357.04 433,00^ 
* from baseline 
n= 10 8 7 1 1 1 1 
Median % change 〇 qo -72.15 95.05 29.81 122.07 70.01 103.59 
bnam from baseline 
n = 4 3 3 3 3 3 3 
Table 3.12: The monthly median percentage changes from baseline of serum OC level 
of the skeletal mature goats within 6 months after operation 
"/?" represents the sample size of the goats in respective month of the group 
"b" shows the significant difference between the sixth month and the baseline within the 
same group; p = 0.018 
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3.3.5.2 Bone resorption marker - Deoxypyridinoline (Dpd) 
Urinary Dpd is one of the commonest biochemical markers used to analyze 
bone resorption. Similar to blood collection, the baseline of the urine sample was 
collected before ovariectomy or sham operation and the subsequent samples were 
collected monthly after the operation for 6 months. 
The median percentage change of creatinine corrected Dpd concentration in 
Ovx group decreased slightly (34.1%) after six months. However, the Sham group 
showed 2-fold decrease (69.1%) after 6 months of the operation (Figure 3.21). 
Statistical analysis showed that there was neither significant difference of the Dpd 
concentration when the data of the sixth month was compared with the baseline in 
both groups (p = 0.310 and 0.285 in Ovx group and Sham group respectively), nor 
between the Ovx group and the Sham group at the sixth month after the operations 
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Figure 3.21: Median percentage changes from baseline of urinary deoxypyridinotine 
(Dpd) concentration of the skeletal mature goats after the operation 
Urinary Dpd concentration of both the ovariectomized goat (Ovx) and sham operated goat 
(Sham) decreased at the end of the study. There was no statistical change in both the two 
groups. Tabie 3.13 beiow shows the sample sizes of each group In each month. 
Group Month(s) post-op 0 1 2 3 4 5 6 
Median % change ^ ^^ .0.54 15.42 -31.05 -25.36 -26.48 -34.11 
* from baseline 
n= 10 8 7 7 7 7 7 
Wledian % change ^ ^^ 31,32 5.37 -1.24 3,54 -48,88 -69,08 
磁 m from baseline 
n- 4 3 3 3 3 3 3 
Table 3.13: The monthly median percentage changes from baseline of urinary Dpd 
concentration of the skeletal mature goats within 6 months after operation 
"/?" represents the sample size of the goats in respective month of the group 
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3.4 Assessments in skeletal immature goats (Part II) 
3.4.1 Estradiol (E2) assessment 
As shown in Figure 3.22, it is similar to the result of the skeletal mature goat 
that a sharp decrease of 41.8 % in serum E2 concentration was found in the Ovx 
group one month after the operation. The serum E2 level was maintained in a low 
level afterwards. However, the median percentage change of serum E2 concentration 
of the Sham group showed a fluctuated result. It increased at the first two months, 
followed by a decrease up to the forth month. The serum E2 concentration then rose 
up again. Figure 3.22 also showed a larger interquantile range of the median 
percentage change of the E2 concentration in the Sham group when compared with 
that in the Ovx group. 
Statistical analysis showed that significant differences in E2 concentration 
between the Ovx group and the Sham group were observed since the first month after 
the operation (Table 3.14). Whereas significant change was found between the sixth 
month and the baseline in the Ovx group (p = 0.018), it was not the case in the Sham 
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Figure 3.22: Median percentage changes from baseline of serum estradiol (E2) 
concentration of the skeletal immature goats after the operation 
A sigmfleant decrease of E2 concentration was found In the ovariectomy (Ovx) group from 
the first month post-operation. No significant change was observed in the sham operation 
(Sham) group. Significant difference was also found when the Ovx group was compared with 
the Sham group at the sixth month after the operation. Table 3.14 betow shows the p-values 
and the sample sizes. 
Group Month(s) 0 1 2 3 4 5 6 
二 。 h 二 = 0.00 -41.84^ -35.85^ -38.53^ -36.20^ -49.11^ -35.13^' Ovx from baseline 
n= 8 8 8 7 7 7 7 
^^edianjo Change • � � 1 3 . 5 0 57.57 4 5 . 4 1 5 . 7 6 2 5 . 1 0 3 0 . 9 8 
Sham from baseline 
n= 4 4 4 4 4 4 4 
Table 3.14: The monthly median percentage changes from baseline of serum estradiol 
(E2) concentration of the skeletal immature goats within 6 months after operation 
"/?" represents the sample size of the goats in respective month of the group 
"a" shows the significant difference between the two groups in the same month; p < 0.05 
"b" shows the significant difference between the sixth month and the baseline vvithi门 the 
same group; p = 0.018 
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3.4.2 Bone mineral density (BMD) measurement - by peripheral Quantitative 
Computed Tomography (pQCT) 
3.4.2.1 Iliac crest biopsy 
Figure 3.23 showed that the median percentage change from baseline of 
BMD in both the Ovx group and Sham group increased six months after the 
operation. However, there was 10.3 % increase in BMD in the Ovx group while the 
BMD increased only 1.8 % in the Sham group (Table 3.15). No statistical significant 
difference was found in the BMD before and after the operation for the both groups 
(p = 0.398 and 0.715 for Ovx group and Sham group respectively). The difference in 
the iliac crest BMD for the Sham and Ovx groups were also not significant six 
months after the operation (p = 0.927). 
3.4.2.2 Lumbar vertebra, calcaneum and humeral head autopsy 
Only the seventh lumbar vertebra (L7) was used for BMD measurement in 
this part. Together with the calcaneum and humeral head, all these specimens were 
collected after the goat had been euthanized. Since each goat contributed one pair of 
calcaneum and humerus, the mean BMD of each pair of specimens from the same 
goat was calculated before statistical analysis. 
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The median BMD of the L7 of the Ovx group was 0.05 g/crn^ higher than 
that of the Sham group (Figure 3.24 and Table 3.16). Owing to the large interquantile 
range of the two groups, there was no significant difference between the two groups. 
However, the median BMD of both calcaneum and humeral head of the Ovx group 
were, 0.05 g/cnr and 0.02 g/cnr respectively, lower than that of the Sham group 
(Figure 3.25 and Figure 3.26). The large variation of the data resulted in non-
significant difference. 
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Figure 3.23: Median percentage changes f rom baseline of the BMD of iliac crest 
biopsy of the skeletal immature goats after the operation 
The BMD of both the ovariectomy (Ovx) group and the sham operation (Sham) group 
changed non-significantly 6 months after the operation. The sample sizes of the groups in 
each month are showed in Table 3.15 below. 
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Group Month(s) post-operation 0 6 
Median % change from baseline 0.00 10.34 
Ovx 
n = 8 7 
Median % change from baseline 0.00 1.81 
Sham 
n = 4 4 
Table 3.15: Median percentage changes of the BMD of iliac crest biopsies in the 
skeletal immature goats 6 months after the operation 
"n" represents the sample size of the goats in respective groups 
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Figure 3.24: Median of BMD (g/cm^) in L7 of the skeletal immature goats after 
operation 
The difference of BMD between the ovariectomized group (Ovx) and the sham operated 
group (Sham) was not significant at the end of the study . Sample sizes and p-value are 
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Figure 3.25: Median of BMD (g/cm^) in calcaneum of the skeletal immature goats after 
operat ion 
The BMD of the ovariectomized group (Ovx) was not statistical different to that of the sham 
operated goats (Sham) at the end of the study. The sample sizes and p-value are shown in 
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Figure 3.26: Median of BMD (g/cm^) in humeral head of the skeletal immature goats 
after operation 
No statistical difference was found in the BMD of the ovariectomized group (Ovx) when 
compared with that in the sham operated goats (Sham) at the end of the study. Table 3.16 





Ovx (n = 7) Sham (n = 4) (Ovx-Sham) 
Lumbar vertebra (L7) 0.52 0.46 0.06 0.109 
Calcaneum 0.39 0.44 -0.05 1.000 
Humeral head 0.50 0.52 -0.02 1.000 
Table 3.16: The BMD (g/cm^) of different regions of the skeletal immature goats 
measured by pQCT 
"n" represents the sample size of the goats in respective group. 
3.4.3 Biomechanical tests 
3.4.3.1 Screw pullout test 
It was found that the median ultimate pullout strength of cancellous bone of 
the Sham group was higher than that of the Ovx group in L4 and distal metaphysis of 
tibia by 24 N and 396 N respectively. However, it was not the case in distal 
metaphysis of femur where the Ovx group required 330 N more than the Sham 
group. For the cortical regions, it was similar to the distal metaphysis of femur that 
the ultimate pullout strength of the diaphysis of femur of the Ovx group was 92 N 
larger than that of the Sham group, but this observation in the diaphysis of tibia was 
reversed. An extra 703 N was needed to pullout the screw from the diaphysis of tibia 
of the Sham group (Figure 3.27 To Figure 3.31). Nonetheless, the differences of the 
screw pullout strength between the two groups were not significant statistically in 
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Figure 3.27: Median screw pullout strength (N) f rom the lumbar vertebra 4 (L4) of the 
skeletal immature goats 
The screw pullout strength of the ovariectomized group (Ovx) was not statistical different to 
that of the sham operated goats (Sham) at the end of the study. Table 3.17 states the sample 
sizes and p-value. 
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Figure 3.28: Median screw pullout strength (N) from the distal metaphysis of the femur 
of the skeletal immature goats 
There was no significant difference between the ovariectomy (Ovx) group and the sham 
operation (Sham) group in the screw pullout strength from the distal metaphysis of femur at 
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Figure 3.29: Median screw pullout strength (N) f rom the diaphysis of the femur of the 
skeletal immature goats 
Similar to distal metaphysis, there was no significant difference in the screw pullout strength 
from the diaphysis of femur between the ovariectomy (Ovx) group and the sham operation 
(Sham) group at the end of the study. Table 3.17 below shows the sample sizes and p-value. 
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Figure 3.30: Median screw pullout strength (N) from the distal metaphysis of t ibia of 
the skeletal immature goats 
Although the median screw pullout strength of the sham operated goat (Sham) was higher 
than that of the ovariectomized goat (Ovx), the difference was not significant. Sample sizes 
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Figure 3.31: Median screw pullout strength (N) from the diaphysis of tibia of the 
skeletal immature goats 
The median screw pullout strength of the ovariectomized goat (Ovx) was nearly the same as 




Ovx (n = 7) Sham (n = 4) (Ovx-Sham) 
Lumbar Vertebra (L4) 1756 1780 -24 (-1.3%) 0.786 
Cancellous 2170 1840 330 (17.9%) 0.183 
Femur 
Cortical 1864 2260 -396 (-17.5%) 0.095 
Cancellous 1682 1590 92 (5.8%) 0.381 
Tibia 
Cortical 2807 3510 -703 (-20.0%) 0.905 
Table 3.17: The median ultimate strength (N) of screw pullout test at different regions 
of the skeletal immature goats 
"n" represents the sample size of the goats in respective group. 
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3.4.3.2 Indentation test 
The analysis showed that the calcaneum of the Ovx group contributed nearly 
the same resistant energy as that of the Sham group (0.50 J and 0.57 J respectively) 
(Figure 3.32). As a result, no significant difference was found in the median 
indentation energy between the two groups (Table 3.18). Although the humeral head 
of the Ovx-group required 0.13 J more than the Sham group during the indentation 
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Figure 3.32: Median indentation work done (J) from the calcaneum of the skeletal 
immature goats 
The indentation work done of the ovariectomized goats (Ovx) was not statistically different 















Figure 3.33: Median indentation work done (J) from the calcaneum of the skeletal 
immature goats 
The difference in the indentation work done of the ovariectomized goats (Ovx) was not 
significant when compared with that of the sham operated goats (Sham). Table 3.18 below 
shows the p-value and sample sizes. 
Group DIff. 
Region “ I T (Ovx-Sham) p-value 
Ovx (n = 7) Sham (n = 4) ^ , 
Calcaneum 0.50 0.57 -0.07 (-12.3%) 0.857 
Humerus 0.71 0.57 0.14 (24.6%) 0.400 
Table 3.18: The median indentation work done (J) of the calcaneum and humeral head 
of the skeletal immature goats 
"n" represents the sample size of the goats in respective group. 
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3.4.4 Biochemical markers 
3.4.4.1 Bone formation markers 
3.4.4.1.1 Bone-specific alkaline phosphatase (BALP) 
A slight increase (48 %) of median percentage change of BALP activity was 
observed in the Ovx group 6 months post-operatively (Figure 3.34). However, the 
change was not significant (p = 0.091). In the Sham group, the BALP activity 
fluctuated after the operation. The BALP activity increased during the first 4 months, 
but then dropped at the fifth month and finally increased up to 153 % of the baseline 
at the sixth month. In spite of this, no statistical significance was found (p = 0.144). 
Moreover, no significant difference was observed between of the two groups after 6 
months (Table 3.19). 
3.4.4.1.2 Osteocalcin (OC) 
It was similar to the BALP activity that the change of OC level of the goats 
in the Ovx group was mild when compared with that in the Sham group. It increased 
in the first month post-operatively and then decreased continuously. There was only 
6.4 % increase in median percentage change at the sixth month when compared with 
its baseline. Although the OC level of the Sham group also increased in the first 
month after the operation and decreased afterwards, it increased sharply starting from 
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the fifth month and increased by 421 % finally (Figure 3.35). Owing to the large 
interquantile range at the sixth month of the Sham group, there was no significant 
change when the OC level of the both groups at the sixth month were compared with 
their respective baselines (p = 0.176 and 0.465 for Ovx group and Sham group 
respectively). Moreover, there was also no significant difference between the two 
groups at the sixth month post-operation (p = 0.78) (Table 3.20). 
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Figure 3.34: Median percentage changes f rom baseline of serum bone=specific 
alkaline phosphatase (BALP) of the skeletal immature goats after the operation 
Both the increases of BALP activity observed in the ovariectomy (Ovx) group and the sham 
operation (Sham) group after the operation were not significant although there was 153 % 
increase in the Sham group. The sample sizes of each group in each month are showed in 
Table 3.19 below. 
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Group Month(s) post-op 0 1 2 3 4 5 6 
Median % 
change from 0.00 50.56 0.52 48.41 18.61 45.76 48.36 
Ovx baseline 
n- 8 8 8 7 7 7 7 
Median % 
change from 0.00 2.77 64.53 52.46 107.13 -45.30 153.22 
Sham baseline 
n= 4 4 4 4 4 4 4 
Table 3.19: The median percentage changes from baseiine of the serum BALP activity 
of the skeletal immature goats 
"n" represents the sampie size of the goats in respective month. 
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Figure 3.35: Median percentage changes from baseiine of serum osteocalcin (OC) 
level of the skeletal immature goats after the operation 
An increase of OC ievei was observed in the sham operated goat (Sham) 6 months after the 
operation. However, there was no significant difference in both the Ovx group and Sham 
group. The sample sizes of each group in each month are showed in Table 3.20 below. 
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Group Month(s) 0 1 2 3 4 5 6 
Median % change 
0.00 50.67 37.99 40.58 41.01 18.91 6.39 
Ovx from baseline 
n= 8 8 8 7 7 7 7 
Median % change 
0.00 116.69 27.00 -15.16 19.28 139.82 421.28 
Sham from baseline 
n = 4 4 4 4 4 4 4 
Table 3.20: The median percentage changes from baseline of the serum OC level in 
skeletal immature goats 
"n" represents the sample size of the goats in respective month. 
3.4.4.2 Bone resorption marker — Deoxypyridinoline (Dpd) 
In contrast to the two bone formation markers, Dpd concentration of the 
Ovx group decreased slightly after the operation. There was a non-significant 28.2 % 
decrease in median percentage change at the sixth month after the operation (p = 
0.116). On the contrary, the Dpd concentration of the goat increased after the sham 
operation and was 91.8 % higher after 6 months. However, the high variation of the 
data in the sixth month resulted in a non-significant change when it was compared 
with the baseline value (p = 0.465) (Figure 3.36). No statistical significance was 
found when comparing the median percentage change of the two groups 6 months 
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Figure 3.36: Median percentage changes from baseline of urinary deoxypyridinoline 
(Dpd) concentration of the skeieta! immature goats after the operation 
Urinary Dpd concentration of the ovariectomized goat (Ovx) decreased but that of the sham 
operated goat (Sham) increased at the end of the study. However, there was no statistical 
difference in both the two groups at the end of the study. Tabie 3.21 beiow shows the sample 
sizes of each group in each month. 
Group Month{s) 0 1 2 3 4 6 6 
Median % change 
0.00 -16.37 -0.78 -23.16 -24.07 -29.04 -28.15 
Ovx from baseline 
n= 8 8 8 7 7 7 7 
Median % change 
0.00 16.28 -3.44 79.08 79.60 50.10 31.80 
Sham from baseline 
n = 4 4 4 4 4 4 4 
Table 3.21: The median percentage changes from baseline of the urinary Dpd 
concentration in skeletal immature goats 






Chapter 4: Discussion 
Osteoporosis, defined by The World Health Organization (WHO) in 1994, is 
a condition in which the bone mineral density (BMD) is 2.5 standard deviation (SD) 
lower than the mean value for young normal people (Kanis J.A. et al., 1994). 
Osteoporosis affects mainly the elderly, especially the postmenopausal women. The 
cancellous bone, especially the hip, will fracture easily even with a simple fall 
because there is a reduction in number and size of trabeculae primarily in cancellous 
bone. This phenomenon also explains why osteoporotic bone has a low “ implant-
holding power". Zink et al in 1996 and Stromsoe et al in 1993 stated that loosening 
of implants from osteoporotic bone is common clinically. 
Osteoporotic bone fracture at hip and spine may cause serious complications 
including loss of mobility and independence, and even death. As the worldwide 
aging population, many nations are spending huge amount of money on dealing with 
osteoporosis and osteoporotic bone fractures annually (Or H.Z. et al., 1999; Philips 
S. et al., 1988; Kanis J.A. et al., 1992; Osteoporosis Working Group, 1998). It is not 
doubted that establishment of a large osteoporotic animal model can provide a 
platform for further in vivo osteoporotic fracture studies that will benefit our society. 
We thus aimed to establish a large osteopenic animal model by using Chinese 
mountain goats. The development of osteopenia was assessed by the changes of bone 
mineral density, biomechanical tests and biochemical markers. The best parameter 
for monitoring the development of osteopenia was also suggested. 
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After going through several scientific literatures, we found that there was no 
agreed definition of osteoporosis in animals. There was also no researchers claimed 
that their animal models met the criterion of osteoporosis set by the WHO. For our 
goat model, the normal mean of BMD of young goats has not ever been reported. 
Applying the human definition of osteoporosis to animals is also inappropriate 
because there are variations in the biological and physiological conditions between 
human and other animals. Therefore in our study, we assumed that goats having low 
BMD are osteopenic. 
4.1 Experiences from other osteoporotic animal models 
Ovariectomy is commonly used to induce postmenopausal bone loss in 
many animals as introduced in Chapter 1. After compared with other animal models 
and considered the climatic factors in Hong Kong, we hypothesize that goat is a 
potential and the most appropriate model for the studies related to osteoporotic 
fracture fixation. 
Dietary calcium intake affects bone remodelling. In 1979, Matkovic V. et al 
reported that higher bone density and lower prevalence of bone fracture were 
observed in both genders in a community with high calcium intakes (Matkvoic V. et 
al,, 1979). Low calcium diet is therefore recognized as one of the methods to 
establish osteoporotic animal model. In 1997, Jiang Y et al used the ovariectomized 
rat with calcium restricted diet to investigate the long-term changes in bone mineral 
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and biomechanical properties of their vertebrae and femur They found that restricting 
.calcium intake after ovariectomy resulted a lower BMD and compression strength. 
The supplementation of low calcium diet therefore can promote the decrease in bone 
mineral density in our ovariectomized goat model. 
In Hong Kong, goats keeping in the government slaughterhouse are 
originally intended for slaughtering. Most goats are sold young to provide soft 
texture mutton. Therefore skeletal immature goats are easier to be obtained. The 
chance to get a healthy skeletal immature goat is much higher than to get a healthy 
skeletal mature one. It is also the ground that the higher mortality was found in the 
skeletal mature goats. From the economical point of view, it is more expensive to 
supply low calcium diet for goats. Hence, we studied if skeletally immature goats fed 
with normal diet can give rise to an osteopenic animal model. 
4.2 Ovariectomized skeletal mature goats fed with low calcium diet suffered 
from osteopenia 
In contrast to natural menopause which results in a progressive decline in 
hormonal level, ovariectomy causes a sudden decline of it. According to Rodgers 
J.B. and his colleagues, the serum estradiol concentration in ovariectomized animals 
declined suddenly after ovariectomy (Rodgers J.B. et al., 1993). This observation 
agreed with our result in the chan2;e of serum estradiol concentration in the 
O 。 
ovariectomized goats. 
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Only the hormonal change cannot distinguish whether an animal is suffering 
from osteopenia. Animal models of osteopenia were commonly assessed by 
measuring the changes of BMD (Turner A.S. et al., 1995; Wronski T.J. et al, 1989; 
Hornby S.B. et al., 1995; Wronski T.J. et al., 1991) and biochemical markers (Kalu 
D.N., 1991; Cahoon S. et al, 1996; Frolik C.A. et al, 1996; Goulding A. et al., 
1996). Apart from these assessments, our goat model was also assessed by 
photodensitometry (based on X-ray film images) and biomechanical tests (screw 
pullout test and indentation test). Both of them showed the significant decrease in 
BMD in the ovariectomized skeletal mature goats. 
In the measurement of BMD of the iliac crest biopsies by pQCT, the BMD 
of the second iliac crest biopsy (collected six months after the ovariectomy) of the 
ovariectomized goat was obviously lower than the baseline value (collected before 
the ovariectomy). Moreover, the BMD of the second iliac crest biopsy of the 
ovariectomized goat was significant lower than that of the sham operated goat. It 
confirmed that ovariectomy caused a decrease in BMD in the goats. Besides, the 
microradiography of the iliac crest biopsy showed that the number of trabeculae in 
the ovariectomized goats decreased when compared with that of the sham operated 
goats. The trabecular connection was also reduced. It indicated that 
microarchitectural deterioration of bone tissues occurred in the ovariectomized 
skeletal mature goats fed with low calcium diet. 
The successful establishment of an osteopenic goat model was further 
proved by the results of BMD measurement of bone autopsy. Although it is the in 
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vivo BMD value measured by Dual Energy X-ray Absorptiometry (DEXA) that 
defines osteoporosis in human, in vitro BMD measurement is still the crucial 
parameter when evaluating an osteoporotic animal model. 
The BMD values of all the autopsies including the lumbar vertebrae (L2 and 
L7), calcaneum and humeral head in the ovariectomized goats, were significantly 
lower than that of the sham operated goat six months after the operation. Similar 
observations were found in previous studies. Turner found that the BMD in the 
vertebrae (L4 - L6 / L5 - L7) was significantly lower in the ovariectomized ewes 
compared to the Sham group six months after the operation (Turner A.S. et al., 
1995). Hornby also reported that the total body BMD was reduced significantly in 
the ovariectomized ewes when compared to the Sham group (Hornby S.B. et al., 
1995). Moreover, in the well-recognized rat model, the ovariectomy-induced BMD 
decrease was well documented (Kimble R.B. et aL, 1994; Goulding A. et al., 1996; 
VaninC.M. et al., 1995). 
Photodensitometry provides a non-invasive consecutive follow-up analysis 
of the bone mineral density of the goats after operation. In skeletal mature goats fed 
with low calcium diet, the standardized bone density (standardized with the thickness 
of the Aluminum Step Wedge (ASW) calibrator) of the metaphyses of the proximal 
tibiae and calcaneus in the ovariectomized goats decreased gradually and with 
significant difference at the sixth month after the operation. This significant decline 
was consistent with the decrease of BMD in the iliac crest biopsy. It also indicated 
that BMD started to decline after ovariectomy. However, there was no significant 
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change in the standardized bone density with time in the sham operated goat, which 
indicated that sham operation did not affect the BMD in the goats. 
In the photodensitometric analysis, some X-ray images were developed 
poorly and led to inconsistent results: In the metaphysis of proximal tibia, the 
inconsistent increase of the standardized bone density in the second month post-
operation of the ovariectomized goats and in the sixth month post-operation of the 
sham operated goats was due to the poor quality control during the X-ray image 
development. The same problem also resulted a sudden decrease in the standardized 
bone density in the forth month post-operation of the sham operated goats. In the 
analysis of the calcaneum, the significant decrease of the standardized bone density 
in the third month of the ovariectomized goats, and the extraordinary elevation of 
that in the third and sixth months post-operation of the sham operated goats were 
also caused by the improper control of X-ray image development. All the remaining 
X-ray images were developed satisfactorily. 
In our study, the poor quality of osteoporotic bone in the ovariectomized 
goats was shown by both the screw pullout test and the indentation test. As 
.mentioned in the previous section (Chapter 1), the dramatic decrease of the number 
of trabeculae in cancellous region, and the common observation of loosening of 
metallic implants from fracture-fixed bone are the characteristics of osteoporotic 
bone. It simply implied that, from the mechanical point of view, osteoporotic bone 
could not withstand the same external force as normal bone. 
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In the screw pullout test, the pullout strength from all the cancellous regions 
tested in the ovariectomized goat was significantly lower than that of the sham 
operated goat. The result was consistent with previous studies (Chapman J.R. et al., 
1996; Koranyi E. et al., 1970) which reported that screw pullout strength was 
significantly positive correlated with BMD. Similar results were also observed in the 
cortical regions where the pullout strength in the ovariectomized goats was also 
lower than the sham-operated control though it was insignificant. The insignificant 
difference may be due to lower surface to volume ratio in the cortical bone compared 
with the cancellous bone. The number of bone remodelling units per volume is 20 
times higher in cancellous than in cortical bone. Most metabolic activity thus occurs 
in cancellous region. Some articles reported that the bone turnover rate in cancellous 
bone is approximately eight times more rapid than that in the cortical bone (Marie-
Christine de Vernejoul, 1998). Any imbalance in bone metabolism and hence BMD 
changes will first be detected in the cancellous bone. The screw pullout strength in 
the cortical regions may reach significant level with larger sample size and longer 
time. 
Indentation test can be regarded as a simple compression test. In the test, 
less energy was required to indent the calcaneum and humeral head of the 
ovariectomized goat. It demonstrated the poor bone quality (a common clinical 
observation in osteoporotic patients) of the ovariectomized goat. Similar result was 
found in the ovariectomized rat model by Peng et al in 1997. They stated that the 
maximum load of the femoral neck of the sham animals increased during the 
experiment, and was clearly higher than that in the ovariectomized group at all time 
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points. Compression test on cancellous bone in other regions were also used to show 
the relationship between the bone strength and BMD or age (McCalden R.W. et al., 
1997; Lewandrowski K.U. et al., 1998; Gibson L.J.，1985; Mitton D. et al., 1997). 
All these studies showed a positive correlation between bone mineral density and the 
compression strength. 
Mechanical strength is often used to represent the result of compression test. 
In our design, cancellous bone surface was partially indented by a stainless steel rod 
of standardized diameter. An indentation was created in the cancellous bone after the 
test. The presence of shearing force (between the indenting trabeculae and non-
indented trabeculae) and friction (between the stainless steel rod and the trabeculae) 
during indentation would result in overestimation of the maximum strength. 
Furthermore, cancellous bone is composed of individual trabeculae. Maximum 
indentation strength may be affected by the difference in the architectural distribution 
of individual trabecula. However, total work done accumulated within a fixed 
displacement (3 mm in our test) minimizes this effect. The total work done is more 
precise to represent the mechanical behaviour of the bone within the whole 
indentation process. 
In the analysis of biochemical markers, percentage change of serum bone-
specific alkaline phosphatase (BALP) and osteocalcin (OC) level were measured as 
bone formation markers. Serum BALP activity has been recognized as a reliable 
indicator of osteoblast activity. For example, Leung et al in 1993 demonstrated that 
the plasma level of the BALP is a sensitive and reliable measure of the healing 
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response following fractures. The serum OC levels represent the activity of fully 
differentiated non-dividing mature osteoblasts and correlate with new bone 
formation. Cole et al in 1990 shown that OC level elevated in infants, children, and 
in patients with conditions characterized by increased bone metabolism. The urinary 
deoxypyridinoline (Dpd) concentration was assessed as bone resorption markers. It is 
one of the pyridinium crosslinks of Type I collagen in bone matrix. During bone 
resorption, the crosslinks are broken down, the Dpd is released into the circulation 
and then excreted via the kidney (Seibel M.J. et al., 1992; Delmas P.D. et al., 1991; 
Eastell R. et al., 1997). Therefore, the urinary Dpd concentration indicates the bone 
resorption rate. 
For the bone formation markers, we found that there was no significant 
difference between the ovariectomized goat and the sham operated goat. Although 
bone-specific alkaline phosphatase (BALP) increased significantly in the 
ovariectomized goats six months after the operation, a non-significant elevation of 
BALP activity was also observed in the sham operated goats. Numerous studies 
proved that BALP is one of the specific bone formation markers for human (Leung 
K.S. et al, 1993; Riis B.J., 1991; Bikle D.D., 1997; Riggs B.L. et al., 1995). 
However, Kyd RA. et al reported in a clinical study in 1998, the change of BALP 
activity was not useful in the detection of osteoporosis as it did not correlate with the 
BMD change. Besides, the specificity and reliability of the assay (ABA-100® 
procedure of the ABBOTT VP System via Wheat Germ Lectin (WGL) precipitation) 
on the measurement of the serum BALP of goats has not been published. 
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The percentage change of serum OC level in the goats was similar to that of 
the BALP activity in this study. OC level increased after the operation in both the 
ovariectomized and the sham operated goats. However, no significant difference was 
found between the two groups. In fact, vitamin K in diet and the renal function of 
goats may affect the OC level in the serum of the goats 
OC concentration in bone is vitamin K dependent. Ziambaras K. and 
Ciciletti R. in 1998 stated that Vitamin K-deficient diets decreased whereas its 
supplementation increased OC level in bone. The vitamin K content in the diet of our 
goats had not been monitored in this study. Changes of OC level in the goats may be 
thus affected by the diet. Further studies can be done to prove this hypothesis. 
Besides, renal function is another factor that will affect the serum OC level. 
Only 10 to 25 % of newly synthesized OC are released into the circulation in human 
(Price RA., 1985) and this circulating OC has a short half-life and is almost entirely 
cleared by kidney (Price RA. et al., 1981). When renal function is severely impaired, 
circulating OC increases dramatically (Delmas RD. et al., 1983). 
Furthermore, the specificity of the OC ELISA may cause imprecise results 
in the study. Since it has not yet proven that the OC ELISA kit (NovoCalcin - Metra 
� 
Biosystems，California, USA) is specific to goats. 
For the bone resorption marker, our results showed that the Dpd 
concentration in both the ovariectomized and the sham operated goats decreased 
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insignificantly six months after the operation. There was also no statistical difference 
between the two groups. Such results were different from that reported by Yoshida Y. 
et al in 1998 and Ederveen A.G.H. et al in 1999. Their findings demonstrated 
significant increase of Dpd concentration after ovariectomy in beagles and rats. One 
possible explanation is that the diurnal variations may affect the concentration of 
Dpd greatly. The Dpd values can oscillate up to 100 % within a 24-hour period, from 
peak at night to nadir during daytime (Schlemmer A. et al., 1992; Blumsohn A. et 
al” 1994). 24-hour urine collection is an ideal method but it is difficult to achieve in 
animal model. Besides, some literatures reported that early morning urine sample 
after an overnight fast yields higher value of Dpd (Uebelhart et al, 1991). They 
proposed that the first void urine sample in the morning should be collected for Dpd 
analysis. Nevertheless, we could not collect the first morning void urine sample from 
the goats and thereby the variation of Dpd concentration measured in our study was 
large. 
Moreover, the unexpected decrease of the Dpd concentration in goat urine 
may also be attributed to the unknown specificity of the antibodies of the ELISA kit 
(Pyrilinks-D - Metra Bio systems®, California, USA) to the urinary Dpd of the goats. 
The overall variation of the results of the biochemical markers was great in 
the present study. It might be due to the inconsistency of the age of the goats. 
Although the goats could be distinguished into skeletal mature or immature by 
radiography, the exactly age of individual goat was unknown. Bone remodelling rate 
in each of the individual goat might be different. 
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Further study is necessary to confirm the specificity of the antibodies in the 
ELISA kits applied in this study for goats. 
4.3 Technique of ovariectomy, calcium content in diet and skeletal maturity are 
the determinants of the successful establishment of osteopenic goat model 
The success of the establishment of the osteopenic goat model in our study 
depends primarily on the technique of ovariectomy, calcium content in the diet and 
the skeletal maturity of the goats. Since estrogen is primarily produced from ovary, a 
complete bilateral ovariectomy should be performed. The excised organ was 
examined by histology. The operation was claimed to be successful only when the 
sole characteristics of ovary were found or re-ovariectomy should be performed. The 
sudden decline in serum estradiol concentration in the ovariectomized goat after the 
operation was consistent with the results of Rodgers et al in 1993. This further 
confirms the success of ovariectomy. 
In order to increase the chance of getting a successful osteopenic goat 
model, low calcium diet was provided to the ovariectomized skeletal mature goat. 
The amount of calcium intake affects bone remodelling. During calcium depletion, 
serum calcium tends to fall, which stimulates the secretion of parathyroid hormone 
(PTH) and the synthesis of calcitriol (a vitamin D metabolite which increases the 
efficiency of bone absorption). Both the PTH and calcitriol in turn activate bone 
remodelling (Pettifor et a/” 1984; Kalu and Masoro, 1990). In fact, not all the 
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postmenopausal women are suffering from osteoporosis. Johnell et al in 1995 stated 
that low calcium diet is associated with an increase in the risk of hip fracture in the 
elderly women. It implies that low calcium diet may increase their risk of 
establishing osteoporosis. The supplementation of low calcium diet was thus 
increased the probability of bone loss in our ovariectomized goats. 
On the other hand, the skeletal maturity of the goats is another crucial factor 
for the successful development of osteopenia. Practically, both Turner et al and 
Hornby et al developed their osteoporotic animal model by using ewes of age 
between 7 - 9 years old (Turner A.S. et al., 1995; Hornby S.B. et al., 1995). The 
lifespan of sheep and goat is approximately 12 years on average (Lam K.H., 1995). 
No literature reported the development of osteopenia in young ewe. In our study, 
osteopenia could not be successfully established in the skeletally immature goats fed 
with normal calcium diet six months after the ovariectomy. The increase in the BMD 
of iliac crest biopsy of the ovariectomized skeletally immature goat was higher than 
that of the sham operated one, but without statistical significance. The results of all 
the biomechanical tests were inconsistent in the skeletal immature goats. No 
difference in the bone quality between the ovariectomized goat and the sham 
operated goat could be observed six months after the operation. In a nutshell, 
ovariectomy cannot induce osteopenia in the skeletal immature goats fed with normal 
calcium diet within six months post-operatively. 
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4.4 Bone mineral density (B MD) measurement of the iliac crest biopsy by 
peripheral Quantitative Computer Tomography (pQCT) is the most reliable 
parameter for monitoring the development of osteopenia in living goats 
Among those parameters that showed significant difference between the 
ovariectomized goat and the sham operated goat, BMD of the iliac crest biopsy 
assessed by peripheral Quantitative Computer Tomography (pQCT) is the best 
indicator of osteopenia. Comparing all parameters measured by pQCT (iliac crest 
biopsy, lumbar vertebrae, calcaneum and humeral head), only iliac crest biopsy 
allows the continuous monitoring of BMD changes. Bone autopsies (lumbar 
vertebrae, calcaneum and humeral head) only permit the end-point measurement of 
BMD. In addition, BMD measurement of the iliac crest biopsy by pQCT also enables 
the assessment of the model in individual animal without control group. 
Biomechanical strength of bone is one of the important risk factors of 
fracture. Direct biomechanical testing of bone provides more information about 
mechanical integrity of bone (Peng Z. et al., 1994). Nonetheless, data collected is 
difficult to compare with the one obtained in other laboratories even though the same 
animal model is used. This argument is supported by Turner and Burr who pointed 
out that there was no standard method on the assessment of mechanical strength of 
bone (Turner C.H. et al., 1993). Biomechanical tests in different testing speeds, 
fixation methods and loading devices result in different findings in different 
laboratories. Even though all the procedures of screw insertion, screw pullout and 
indentation are standardized, the different sizes and shapes of the bone still makes 
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comparison with other laboratories impossible and large variations in the data are 
unavoidable. Besides, only end-point measurement can be performed for 
biomechanical tests after the animal has been euthanized. It is too invasive to the 
animal if biopsy is taken for the test. 
Although photodensitometry of proximal tibia and calcaneum allows both 
baseline and follow-up measurements, its sensitivity is lower than that of pQCT. The 
high precision and reproducibility of pQCT is well recognized (Ruegsegger P. et al., 
1976; Schneider P. et al., 1996), with long-term reproducibility of 0.3% in in vivo 
studies. Moreover, pQCT can differentiate the cancellous and cortical bone for 
separate analysis. The decrease in BMD during osteoporotic condition can therefore 
be detected earlier (Rico H. et al., 1994). Three-dimensional image of bone 
architecture can be constructed by the pQCT software, which is valuable in the 
biomechanical and structural studies of bone (Dambacher M.A. et al.’ 1998; Muller 
R. et al., 1996; Ruegsegger R, 1994). 
4.5 Further improvement of densitometric measurement 
Notwithstanding the advantages of the pQCT, in vivo follow-up assessment 
after ovariectomy or sham operation cannot be performed in our study. First, 
positioning is one of the factors affecting the precision and reproducibility of the 
measurement (Ruegsegger P., 1996). There are standard moulds for human for 
positioning the tibia and radius. Although custom-made holders fitting the limbs of 
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goats can be made, goats cannot sit just like human to put their limbs onto the 
machine for BMD measurement. Second, due to the limitation of the size of the 
machine, total body or lumbar vertebral BMD cannot be measured. 
Low vertebral BMD is a common risk factor of osteoporotic bone fracture, 
as reflected by the high incidence of osteoporotic vertebral fracture in human. 
Hornby el al, Longcope el al and Vanin el al used the DEXA to measure the lumbar 
vertebral BMD of ovariectomized ewes, monkeys and rats respectively (Hornby S.B. 
et al., 1995; Longcope C. et al., 1989; Vanin C.M. et al., 1995). Although DEXA is 
not as precise as pQCT (Schneider P. et al., 1996), DEXA. is superior to pQCT in 
allowing the follow-up assessment of changes of BMD in goats after ovariectomy or 
sham operation. We will therefore, use DEXA to measure the changes of lumbar 
vertebral BMD of goats in further studies (Figure 4.1). 
• 
^ ^ ^ H M ^ ^ ^ ^ ^ H Figure 4.1: Image of lumbar vertebrae 
A built-in scientific program was used to 
the vivo bone 
content (BMC) of the lumbar vertebra L3 
and L4 (marked with white frames) of 
124 
Discussion 
4.6 Limitations of the presen t study 
Osteoporotic goat model has been established in the skeletal mature goats, 
and the requirements and the parameters for the assessment of osteopenia in the goats 
have been documented. There were still some limitations in our present study. 
All the goats were kept for six months after ovariectomy or sham operation 
in this study. From the result of photodensitometry, it was found that the median 
bone density in both proximal tibia and calcaneum of the ovariectomized goat did not 
reach a plateau within that period (Figure 4.2). We believe that a further decrease in 
BMD, approaching 2.5 SD below the normal mean of BMD as defined by WHO for 
osteoporosis, will be obtained in the goat after a longer period of time post-
ovariectomy. A further reduction in the mechanical strength of the bone will be 
observed then. 
On the other hand, except the iliac crest biopsy, baseline value of the BMD 
measurement of the bone autopsies could not be provided. They were obtained after 
euthanasia of the goat and thus only end-point values were available. The degree of 
variation in the baseline between the ovariectomized goat and the sham operated goat 
is unknown. The data, therefore, just showed the difference between the two groups 
six months after the operation. Osteopenia development in each individual goat could 
not be monitored by this approach. Although the iliac crest biopsy allows baseline 
BMD measurement, the minimum time required for the significant decrease and the 
time required for the decrease to become stable are unclear in the present study. 
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Thus, the optimum time for the establishment of the osteopenia model is unknown. 
Since the biopsies must be harvested from different regions, collection of more than 
two biopsies from goat, though possible, will reduce the reproducibility. 
Furthermore, frequent-operations is life threatening. The availability of DEXA 
machine will certainly solve these problems. 
Another limitation was the variation of time control of the X-ray film 
development in the radiography. Although a timer was used to standardize the time 
of development, difference in only a few seconds would affect the quality of X-ray 
images especially when a freshly prepared developing solution was used. This led to 
large variation in the photodensitometric data. One more limitation was that first 
morning void urine sample, which is proposed for Dpd analysis, could not be 
collected in our study. Although all the urine samples were collected in the morning, 
diurnal variation could not be eliminated. Moreover, twenty-four-hour urine 
collection by intubation via urethra of the goat could not be performed as the goat 
would get rid of the tubing. 
Within the study, the high mortality of the goat, especially in the skeletal 
mature group, was noticed. Not only reduced the sample size, such mortality might 
also affect the results during data analysis. It was observed that in general, the health 
condition of the skeletal mature goats was poorer than that of the skeletal immature 
ones before the ovariectomy or sham operation. It was believed that owing to their 
old age, their resistance was low and thus they were easier to get sick during the long 
and crowed journey from Mainland China to Hong Kong. Due to the commercial 
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purpose as discussed in Part 4.1, the availability of the skeletal mature goat is so low 
that the chance to get a healthy skeletal mature goat is much lower than to get a 
healthy skeletal immature one. In order to improve the survival of the goat, we have 
communicated with the wholesaler and sought for its help. The skeletal mature goats 
can be transported separately to avoid overcrowding. After their arrival they were 
also cared more intensively by the veterinarians of the Laboratory Animal Services 
Center in our university. 
The unclear of age of the goat also led to large variation of biochemical 
markers as discussed in Part 4.2. If their age can be standardized, it was expected that 
the results of all the photodensitometry, densitometry and biomechanical tests would 
be more convincing. 
Goat is a large animal having the advantage of structural similarity to the 
human long bone. Nonetheless, it is expensive to maintain and look after such a large 
experimental animal. The relative small space of the pen also limits the number of 
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Figure 4.2: Percentage changes f rom baseline of the standardized bone density in the 
goats after ovariectomy (Ovx) 
In both proximal tibia (A) and calcaneum (B), a continuous decrease median curve was 
observed from the percentage changes of standardized bone density (standardized pixel 
density of X-ray film in term of thickness (mm) of Aluminum Step Wedge (ASW) calibrator) of 
the goats after Ovx. No plateau was observed within six months after Ovx in both the 
regions. Although the curve of the calcaneum seemed to reach plateau from sixth month 




4.7 Further studies 
A large osteoporotic animal model is certainly superior to small animal 
models for the study of metallic implants. Increase in sample size is necessary for 
further investigation. 
In vitro studies on the effect of different surgical methods and/or different 
implants for osteoporotic fracture fixation have been published (Hernefalk L. et al., 
1995; Stromsoe K. et al., 1993; Chapman J.R. et al., 1996). The studies were based 
on using either cadaveric bone or artificially synthesized calcium phosphate bony 
material. The biological events at the fracture site or the bone-implant healing 
interface have not been reported in their studies. In fact, only few studies 
documented the biological changes at the bone-implant interface after osteoporotic 
fracture. With the successful establishment of the osteopenic goat model, it is 
encouraging to investigate the performance of different types of implants for in vivo 
osteoporotic fracture fixation. It certainly can provide some valuable information 
such as biocompatibility of the implants and the biology of healing at the bone-
implant interface. New screw design can also be tested. All of these studies are not 
possible without a live osteoporosis animal model. 
Osteoporotic bone fracture fixation with biomaterials is very common 
nowadays. In vitro study demonstrated that biomaterials reinforced the screw pullout 
strength (Mermelstein L.E. et al., 1996). The screw pullout strength is partly 
contributed by the bone-screw interface (Ansell R.H. et al., 1968; Koranyi E. et al., 
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1970) which can be analyzed by histomorphometry (Figure 4.3). The effect of 
biomaterial on the improvement of the interface, and the pullout strength can be 
studied using our osteopenic goat model. Meanwhile, the in vivo effect of the 
biomaterials on fracture healing, bone remodelling and mechanical property can be 
studied. Owing to the fact that osteoporosis is mainly characterized by cancellous 
bone which fractures easily (Lau E.M.C., 1997; Cooper C. et al., 1992; Melton III 
L.J. el al., 1997), lumbar vertebrae of goat is optimum for those studies. 
Figure 4.3: Histomorphometry showing the bone=scr8w 
interface in the lumbar vertebra of goat 
The black shadow at the lower part of the photo is the Icngitudina! 
section of a cancellous screw. Bone-screw interface can be 
caicuiated by summating the contact area of the trabeculae of the 
lumbar vertebra and the screw using an image analysis system. 
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Recently, osteoinductive growth factors such as bone morphogenetic 
proteins (BMP), were found useful to enhance fracture healing. Clinically, Bai et al. 
in 1996, as well as Johnson and Urist in 2000 obtained excellent results when using 
allografts with BMPs for patients with femoral nonunion. Excitingly, as presented by 
Illi O.E. and Feldmann C.R in 1998，as well as Welch R.D. and his colleagues in the 
same year, combination of implant with a drug release system to deliver these growth 
factors will enlarge the field of application of biodegradable implants in the treatment 
of bone fracture. It may remarkably reduce the time for fracture healing and also 
lower the costs of postoperative treatment. However, the technique is still under 
investigation and its applicability for osteoporotic bone fracture fixation has never 
been reported yet. Our osteopenia animal model provides a basis to study and 
improve the technique. 
Study on drug treatment of osteoporosis is also popular in recent years. The 
pharmacological effects of different drugs (inhibit bone resorption and/or enhance 
bone formation) on the treatment of osteoporosis can be investigated using our 
osteopenic goat model. 
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Chapter 5: Conclusion 
For long, osteoporotic hip and spine fractures may cause serious 
complications. Due to the weak structure of osteoporotic bone, loosening of implants 
after surgery occurs very often. We therefore aimed at establish an osteopenic animal 
model so that the special implants and surgical techniques can be studied in vivo. 
From the literature, we found that osteoporotic animal models had been 
established in different species by other research groups. However, most of these 
animals are too small for our study with implant fixation and augmentation 
techniques. In this study, we tried to establish an osteopenic goat model by 
ovariectomy and providing with low calcium diet. Successful ovariectomy (Ovx) was 
implied by a sudden decline of serum estrogen level in the goats. Non-invasive 
photodensitometric analysis showed that the standardized bone density (measured as 
the pixel density of X-ray images) of the proximal tibial metaphysis, and of the 
calcaneum of the goats started to decrease one month after ovariectomy. Similarly, a 
significant drop in bone mineral density (BMD) was detected in the second iliac crest 
biopsy taken 6 months after the goats had been ovariectomized and fed with low 
calcium diet. All these information confirmed the successful establishment of 
osteopenia in the goats. 
Although there was no baseline BMD value taken from our bone autopsy 
samples, the BMD of the samples taken from the Ovx group were significantly lower 
than those taken from the sham operation (Sham) group 6 months after the operation. 
Our findings are in consistent with other studies, which showed that BMD of the 
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ovariectomized ewe and rat were significantly lower than that of the sham control. 
Weak mechanical property, one of the characteristics of osteoporotic bone, 
was confirmed in the skeletally matured ovariectomized goats fed with low calcium 
diet. The screw pullout test and the compression test showed that the screw pullout 
strength and the compression work done were both significantly lower in the 
cancellous regions in the ovariectomized goat than that in the sham operated goat. It 
is believed that our small sample size led to the insignificant lower screw pullout 
strength in the cortical regions. 
In the biochemical tests, no significant difference was observed in the bone 
formation markers (serum bone-specific alkaline phosphatase and osteocalcin) and 
bone resorption marker (urinary deoxypyridinoline) between the Ovx group and the 
Sham group six months post-operation. This may be due to the low level and high 
variation of circulating markers in the goats. Moreover, further study is necessary to 
confirm the specificity of the antibodies in the ELISA kits applied in this study for 
goats. 
In this study, the surgical technique of ovariectomy, the calcium content of 
diet and the skeletal maturity of the goats are the crucial factors in the development 
of the osteopenic goat model. We also found that BMD measurement of an iliac crest 
biopsy by peripheral Quantitative Computed Tomography (pQCT) is the best 
indicator to assess the degree of osteopenia in skeletally matured goats. However, 
because of the small size of the pQCT and the problem of animal positioning, Dual 
Energy X-ray Absorptiometry is recommended to measure the BMD of lumbar 
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vertebrae of goats. We believe that the BMD and the mechanical strength of the 
goats' bones will further decrease if the goats are kept for a longer period of time 
after ovariectomy. 
Our osteopenic goat model can contribute to the in vivo studies of various 
surgical techniques and new designs of implants to improve the method of fixation 
for osteoporotic fractures. We hope that osteoporotic patients can enjoy a better life 
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